NCT05585034
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 recruiting NCT02654587
OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure treatment 3 terminated NCT05956587
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT00280787
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim treatment 2 completed NCT03853187
Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer treatment 2 completed NCT00765687
Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates No drug interventions prevention 4 completed NCT00738387
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer treatment 3 terminated NCT04772287
Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008) treatment 3 not_yet_recruiting NCT03903887
A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT02349633
Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M) treatment 1 / 2 terminated NCT04239833
A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 unknown_status NCT01041833
Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker treatment 3 unknown_status NCT02803333
Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study No drug interventions Not Available Not Available completed NCT02058433
Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 3 unknown_status NCT02967133
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer treatment 2 terminated NCT02568033
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer treatment 0 unknown_status NCT02473133
Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC No drug interventions treatment 2 unknown_status NCT06452433
Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. treatment 2 not_yet_recruiting NCT06575933
A Study of MK-1084 With Midazolam and Digoxin in Healthy Participants (MK-1084-009) treatment 1 not_yet_recruiting NCT03116633
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy No drug interventions Not Available Not Available completed NCT01630733
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer treatment 3 unknown_status NCT04258033
A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG) treatment 2 recruiting NCT02495233
A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI) treatment 1 / 2 terminated NCT02974933
Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer treatment 2 unknown_status NCT03064854
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients treatment 1 terminated NCT05085054
Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT) treatment 2 unknown_status NCT06109454
Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery No drug interventions Not Available Not Available recruiting NCT03811054
The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT02423954
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) treatment 1 / 2 terminated NCT03518554
A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors treatment 1 unknown_status NCT01577654
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer treatment 2 completed NCT02921854
Detection of Circulating Biomarkers of Immunogenic Cell Death No drug interventions other Not Available completed NCT00442754
Dendritic Cells in Lung Cancer No drug interventions treatment 2 completed NCT00063154
Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy treatment 2 completed NCT06336954
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure treatment 2 not_yet_recruiting NCT01885754
Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT02778854
Liquid Biopsy for Detection of Driver Mutation in NSCLC No drug interventions Not Available Not Available unknown_status NCT04641754
A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer treatment 2 unknown_status NCT00896454
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium treatment 2 completed NCT06083454
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC) treatment 1 recruiting NCT00831454
Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection No drug interventions Not Available Not Available completed NCT02839954
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor treatment 1 / 2 unknown_status NCT02930954
Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance treatment 2 unknown_status NCT02779751
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer treatment 1 active_not_recruiting NCT02448251
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer treatment 1 terminated NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT00460551
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer treatment 2 terminated NCT05925751
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT00402051
Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00430651
Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) treatment 3 completed NCT04317651
Crizotinib in ALK Rearranged Non-small-cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03527251
Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC treatment 1 unknown_status NCT04638751
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients No drug interventions Not Available Not Available recruiting NCT04324151
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC No drug interventions Not Available Not Available recruiting NCT04977453
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT02195453
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer No drug interventions treatment 4 unknown_status NCT03871153
Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer treatment 2 terminated NCT01210053
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 unknown_status NCT02747953
Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib treatment 2 completed NCT06546553
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. treatment 1 / 2 not_yet_recruiting NCT02342353
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) treatment 1 terminated NCT04332653
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT03724253
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) No drug interventions diagnostic 2 terminated NCT04703153
LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available active_not_recruiting NCT04978753
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer treatment 2 unknown_status NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT06250777
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases treatment 2 not_yet_recruiting NCT05334277
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA treatment 2 recruiting NCT01666977
Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03228277
Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA treatment 2 completed NCT03245177
Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 withdrawn NCT02319577
GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial treatment 2 unknown_status NCT01221077
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene treatment 2 completed NCT00933777
SORAVE - Sorafenib and Everolimus in Solid Tumors treatment 1 completed NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06300177
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure treatment 3 recruiting NCT05171777
A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT04342377
The Canada Lymph Node Score Project: A Crossover Trial No drug interventions diagnostic 3 completed NCT03978377
Cardiopulmonary Toxicity of Thoracic Radiotherapy No drug interventions Not Available Not Available recruiting NCT00967577
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors treatment 1 completed NCT01808677
Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy No drug interventions Not Available Not Available completed NCT03412877
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer treatment 2 recruiting NCT03237377
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT03573947
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC treatment 2 completed NCT05861947
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies No drug interventions treatment 1 recruiting NCT02010047
Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients No drug interventions diagnostic Not Available completed NCT02000947
A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer treatment 1 completed NCT01933347
Third-line Treatment of Gefitinib in NSCLC Patients treatment 2 completed NCT06545747
Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI No drug interventions treatment 3 recruiting NCT01545947
Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT01023347
A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT01843647
Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients treatment 2 unknown_status NCT00756847
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors treatment 1 completed NCT03594747
A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer treatment 3 completed NCT01640847
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases treatment 2 withdrawn NCT05001347
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors treatment 2 completed NCT02977845
Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety. No drug interventions supportive_care Not Available completed NCT02983045
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors treatment 1 / 2 completed NCT01588145
Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients treatment 1 / 2 completed NCT05559645
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) treatment Not Available recruiting NCT05785845
Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT00588445
Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene treatment 2 completed NCT00970645
Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer No drug interventions diagnostic Not Available terminated NCT02014545
Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer treatment 2 withdrawn NCT01540045
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04193098
Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC treatment 1 unknown_status NCT04148898
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis treatment 2 unknown_status NCT01037998
UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer treatment 2 completed NCT02369198
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC No drug interventions treatment 1 completed NCT00475098
Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) treatment 3 completed NCT00178698
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors treatment 2 unknown_status NCT05574998
First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial treatment 2 recruiting NCT05329298
A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT05715398
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT04822298
Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer treatment 1 terminated NCT00049998
Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT00351598
Lung Tumour Volume Database No drug interventions Not Available Not Available completed NCT05669105
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research No drug interventions Not Available Not Available recruiting NCT05452005
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer No drug interventions diagnostic 1 recruiting NCT05288205
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation treatment 1 / 2 recruiting NCT05103605
Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations Not Available Not Available active_not_recruiting NCT04392505
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study treatment 2 active_not_recruiting NCT04297605
Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 treatment 1 recruiting NCT04865705
Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer treatment 2 unknown_status NCT01871805
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT04237805
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients No drug interventions treatment 1 / 2 recruiting NCT03663205
A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLC treatment 3 completed NCT06180005
Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.) No drug interventions Not Available Not Available recruiting NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT05819905
Radiomics for prEdiction of lunG cAncer biologY No drug interventions Not Available Not Available active_not_recruiting NCT00913705
Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer treatment 3 completed NCT06479005
ETERNALS: Remote Monitoring in Lung Cancer Patients No drug interventions diagnostic Not Available not_yet_recruiting NCT05251805
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery No drug interventions basic_science Not Available recruiting NCT00783705
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia prevention 2 completed NCT03769805
Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC treatment Not Available unknown_status NCT03275597
Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition treatment 1 terminated NCT00240097
Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) treatment 2 completed NCT00960297
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC treatment 2 terminated NCT03396497
Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer treatment 1 unknown_status NCT01598597
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) No drug interventions Not Available Not Available completed NCT05144997
Lorlatinib Continuation Study treatment 4 recruiting NCT01459497
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer No drug interventions treatment 3 completed NCT05347797
Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit No drug interventions diagnostic Not Available unknown_status NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT03958097
Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors No drug interventions other 1 recruiting NCT06255197
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers No drug interventions Not Available Not Available recruiting NCT04041297
Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation No drug interventions Not Available Not Available completed NCT01177397
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma treatment 1 / 2 completed NCT00687297
Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02192697
An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations treatment 1 / 2 terminated NCT06350097
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 recruiting NCT00662597
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer treatment 3 terminated NCT02886897
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT04153097
Real World Observational Study of Pembrolizumab for Chinese Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT04761783
BESPOKE Study of ctDNA Guided Immunotherapy No drug interventions Not Available Not Available completed NCT06276283
DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29) treatment 2 recruiting NCT00077883
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT04266483
Cancer Genome Atlas of China:Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05517083
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer No drug interventions diagnostic Not Available recruiting NCT06195683
Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study. treatment 2 active_not_recruiting NCT02183883
Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity treatment 2 completed NCT03680183
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) Not Available Not Available unknown_status NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT00773383
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. treatment 2 terminated NCT06467383
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced No drug interventions Not Available Not Available not_yet_recruiting NCT06120283
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors treatment 1 recruiting NCT02738983
RT Plus EGFR-TKI for Wild-type NSCLC treatment 2 unknown_status NCT01516983
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation treatment 1 / 2 completed NCT01046383
Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients No drug interventions treatment 3 terminated NCT00826683
Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic 3 completed NCT01998061
Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression treatment 2 unknown_status NCT02468661
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification treatment 1 terminated NCT02635061
Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer treatment 1 terminated NCT02549261
Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer treatment Not Available unknown_status NCT06473961
A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of NSCLC treatment 1 not_yet_recruiting NCT00094861
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05008861
Gut Microbiota Reconstruction for NSCLC Immunotherapy treatment 1 unknown_status NCT00536861
Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer treatment 1 completed NCT01799161
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer treatment 1 withdrawn NCT05085028
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT00130728
A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT05163028
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations No drug interventions treatment 1 recruiting NCT01880528
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer supportive_care 2 completed NCT00866528
Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer treatment 1 completed NCT02044328
Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation treatment 2 completed NCT03209128
Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala No drug interventions Not Available Not Available terminated NCT05347628
Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 active_not_recruiting NCT05878028
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC treatment 2 recruiting NCT05226728
Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer treatment 1 completed NCT03848611
CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). treatment 2 unknown_status NCT02716311
Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer treatment 2 completed NCT03510611
A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers. treatment 1 completed NCT00888511
Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer treatment 2 completed NCT06403111
FMT+Immunotherapy+Chemotherapy as First-line Treatment for Driver-gene Negative Advanced NSCLC treatment 2 not_yet_recruiting NCT02951611
Effects of Acupuncture Stimulation on Systemic Inflammation No drug interventions treatment Not Available unknown_status NCT00982111
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin treatment 3 completed NCT04203511
INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) treatment 3 withdrawn NCT04459611
Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE） treatment 2 unknown_status NCT02338011
Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) treatment 2 / 3 unknown_status NCT06297811
Myeloprotection With Trilaciclib in Pan-cancer Population prevention 2 not_yet_recruiting NCT03911193
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation treatment 2 unknown_status NCT05641493
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation treatment 1 / 2 recruiting NCT05998993
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO) No drug interventions treatment Not Available not_yet_recruiting NCT04636593
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC treatment 2 unknown_status NCT02616393
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases treatment 2 completed NCT04074993
Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays treatment 2 active_not_recruiting NCT04786093
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC treatment 2 recruiting NCT05748093
Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat treatment 4 recruiting NCT03132493
Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient Not Available Not Available completed NCT06476093
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer treatment Not Available recruiting NCT04958993
A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT04970693
A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression No drug interventions treatment 2 unknown_status NCT01473693
Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging No drug interventions Not Available Not Available terminated NCT03217071
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer treatment 2 completed NCT05802771
Lung Cancer Multi-omics Digital Human Avatars for Integrating Precision Medicine Into Clinical Practice No drug interventions Not Available Not Available not_yet_recruiting NCT00271271
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients treatment 2 completed NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04606771
A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC treatment 2 active_not_recruiting NCT01926171
Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases treatment 4 unknown_status NCT01797471
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT03519971
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT05287971
Standard of Care Lifestyle Support for Stage III NSCLC Patients No drug interventions Not Available Not Available withdrawn NCT00620971
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC treatment 2 completed NCT01130571
Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures No drug interventions Not Available Not Available unknown_status NCT03272971
Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors No drug interventions device_feasibility Not Available terminated NCT04180371
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression treatment 1 / 2 recruiting NCT00815971
Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib No drug interventions Not Available Not Available unknown_status NCT05845671
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations treatment 1 / 2 recruiting NCT01038271
Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions supportive_care Not Available completed NCT02403271
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 / 2 completed NCT03908671
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03659578
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer treatment 2 completed NCT00735878
Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer treatment 1 / 2 terminated NCT00283478
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer treatment Not Available completed NCT01258478
Lung Cancer Rehabilitation Study No drug interventions treatment Not Available unknown_status NCT05219578
RTX-224 Monotherapy in Patients With Solid Tumors No drug interventions treatment 1 / 2 terminated NCT04215978
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00175578
Detection of Early Lung Cancer by Serum Protein Expression Profiling No drug interventions Not Available Not Available unknown_status NCT04015778
A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China treatment 2 unknown_status NCT01943578
Value of Physical Capacity Tests in Lung Cancer No drug interventions Not Available Not Available completed NCT03299478
Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05366478
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors treatment 1 recruiting NCT04322578
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC treatment 2 recruiting NCT03499678
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA No drug interventions Not Available Not Available terminated NCT05777278
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression treatment 1 / 2 recruiting NCT05296278
Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC treatment 2 recruiting NCT01528488
Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC No drug interventions prevention 2 / 3 completed NCT03881488
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies treatment 1 active_not_recruiting NCT04852588
Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment No drug interventions treatment Not Available recruiting NCT05351788
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer. treatment 2 recruiting NCT06018688
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients. treatment 2 not_yet_recruiting NCT01707888
VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05668988
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) treatment 3 recruiting NCT00409188
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) treatment 3 completed NCT00874588
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT05648188
A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells No drug interventions Not Available Not Available not_yet_recruiting NCT05230888
Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients No drug interventions Not Available Not Available withdrawn NCT04262388
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation treatment 2 withdrawn NCT03607188
Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer No drug interventions treatment 1 completed NCT01042288
Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC treatment 2 completed NCT00741988
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer treatment 2 completed NCT03624907
Daily vs. Non-Daily SBRT for NSCLC No drug interventions treatment Not Available terminated NCT06198907
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC) treatment 2 not_yet_recruiting NCT02613507
Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer treatment 3 completed NCT02535507
Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer treatment 2 unknown_status NCT04432207
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT05742607
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE) treatment 2 recruiting NCT02733107
The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT04254107
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer treatment 1 terminated NCT05780307
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05801107
Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients treatment 2 active_not_recruiting NCT04878107
SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy treatment 2 unknown_status NCT04193007
The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC No drug interventions treatment 2 unknown_status NCT04622007
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) treatment 2 active_not_recruiting NCT00874107
Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00763607
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT04702607
Functional Lung Imaging With DECT and 4DCT No drug interventions Not Available Not Available recruiting NCT00499109
Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC treatment 3 completed NCT05430009
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer treatment 1 recruiting NCT02016209
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer treatment 2 unknown_status NCT02393209
Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT01977209
Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression treatment 3 unknown_status NCT05313009
Tarlox and Sotorasib in Patients With KRAS G12C Mutations treatment 1 / 2 terminated NCT03624309
Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer treatment 2 unknown_status NCT06355609
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW treatment 2 not_yet_recruiting NCT03008109
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC treatment 3 unknown_status NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT00867009
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT00614809
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer treatment 2 unknown_status NCT02871856
International Lung Screen Trial (ILST) No drug interventions screening Not Available active_not_recruiting NCT02215356
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer treatment 2 unknown_status NCT03629756
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies treatment 1 completed NCT03568656
Study to Evaluate CCS1477 in Advanced Tumours treatment 1 / 2 recruiting NCT00555256
A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT05987956
Pharmacogenomics IND EXEMPT SNP Clinical Study - Alectinib and Single Nucleotide Polymorphisms health_services_research 2 / 3 not_yet_recruiting NCT06497556
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT03129256
An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT04193956
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors No drug interventions Not Available Not Available recruiting NCT01938456
Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer treatment 1 withdrawn NCT01950156
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT01459185
A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 No drug interventions treatment 2 completed NCT04580485
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors treatment 1 completed NCT01763385
Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases treatment 2 unknown_status NCT00259285
Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer treatment 2 terminated NCT04875585
Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC treatment 2 recruiting NCT03553485
Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC No drug interventions treatment Not Available unknown_status NCT03017885
Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy No drug interventions Not Available Not Available completed NCT03461185
Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT06436885
An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer treatment 0 recruiting NCT05542485
PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study No drug interventions Not Available Not Available recruiting NCT05269485
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT05704985
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors treatment 1 recruiting NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 treatment 1 active_not_recruiting NCT01065415
Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT00199615
Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC No drug interventions diagnostic Not Available completed NCT00752115
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer treatment 2 / 3 completed NCT00463515
Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC treatment 2 completed NCT01734915
Detecting EGFR T790M Mutations From Circulating Tumor Cells No drug interventions Not Available Not Available completed NCT03512015
A Mobile Supportive Care App for Patients With Metastatic Lung Cancer No drug interventions supportive_care Not Available unknown_status NCT06305715
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) No drug interventions treatment 2 not_yet_recruiting NCT04754815
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC treatment 2 withdrawn NCT00600015
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT06444815
A Study of VET3-TGI in Patients With Solid Tumors treatment 1 not_yet_recruiting NCT03242915
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease treatment 2 active_not_recruiting NCT05477615
Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases treatment 2 not_yet_recruiting NCT04726215
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer No drug interventions diagnostic 2 recruiting NCT04510415
Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI treatment 1 terminated NCT00718315
A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. treatment 3 completed NCT02591615
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC treatment 2 completed NCT03090737
Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT05919537
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation treatment 1 recruiting NCT05549037
Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC treatment 3 recruiting NCT03700437
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC) No drug interventions supportive_care Not Available completed NCT04644237
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT04258137
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study No drug interventions other Not Available recruiting NCT06007937
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer treatment 1 / 2 recruiting NCT06312137
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) treatment 3 recruiting NCT06245837
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations No drug interventions Not Available Not Available recruiting NCT04133337
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC treatment 1 / 2 unknown_status NCT01944137
Improving Care After Chemotherapy No drug interventions supportive_care Not Available completed NCT04646837
Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models treatment 1 / 2 recruiting NCT03515837
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789) treatment 3 completed NCT00809237
Hydroxychloroquine and Gefitinib to Treat Lung Cancer treatment 1 / 2 unknown_status NCT03736837
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC treatment 2 completed NCT04619537
A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer treatment 2 unknown_status NCT00901537
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer treatment 1 terminated NCT03432637
Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia No drug interventions treatment 3 unknown_status NCT02538432
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors treatment 2 withdrawn NCT00379132
131-I-TM-601 Study in Adults With Solid Tumors treatment 1 completed NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors treatment 1 recruiting NCT01996332
A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05983432
Study to Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors No drug interventions treatment 1 recruiting NCT03774732
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer treatment 3 recruiting NCT01788332
Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN) treatment 2 unknown_status NCT01772732
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC No drug interventions treatment 1 unknown_status NCT05254132
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging No drug interventions Not Available Not Available not_yet_recruiting NCT03517332
Circulating Tumor DNA Exposure in Peripheral Blood No drug interventions Not Available Not Available unknown_status NCT04930432
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04244552
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies treatment 1 terminated NCT02906852
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing No drug interventions Not Available Not Available completed NCT02193152
Pazopanib in Molecularly Selected Patients With Advanced NSCLC treatment 2 terminated NCT02113852
Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients No drug interventions Not Available Not Available completed NCT03836352
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors treatment 2 active_not_recruiting NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT01721252
Tarceva. ICORG 08-41 No drug interventions Not Available Not Available completed NCT05752552
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours No drug interventions treatment 1 recruiting NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT05613452
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT03603652
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung No drug interventions treatment Not Available terminated NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies treatment 1 / 2 recruiting NCT00707252
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer treatment 1 terminated NCT00731952
Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer other 1 completed NCT00787852
A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT06185400
RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations treatment 2 not_yet_recruiting NCT02262000
Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT00319800
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC treatment 2 unknown_status NCT06182800
Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy treatment 2 not_yet_recruiting NCT03411200
Patient Activation Through Counseling, Exercise and Mobilization No drug interventions supportive_care Not Available completed NCT01752400
AUY922 for Advanced ALK-positive NSCLC treatment 2 completed NCT05245500
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion treatment 1 / 2 recruiting NCT04382300
Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions treatment 2 unknown_status NCT04950400
A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC treatment Not Available unknown_status NCT00529100
Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer treatment 1 / 2 completed NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT02447900
Marker Guided Breathhold Radiotherapy in NSCLC No drug interventions treatment 1 completed NCT03056300
A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies No drug interventions other Not Available completed NCT06221800
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects No drug interventions Not Available Not Available recruiting NCT02661100
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients treatment 1 / 2 withdrawn NCT01929200
Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation treatment 2 unknown_status NCT01063400
Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors No drug interventions Not Available Not Available terminated NCT06475300
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT03874000
Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients treatment 2 unknown_status NCT00567359
Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR treatment 2 completed NCT04289259
Tumor Mutational Burden in Lung Cancer Patients No drug interventions Not Available Not Available terminated NCT01058759
Taxotere-Enoxaparin-(ENOXA)-Study treatment 3 terminated NCT05769959
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors treatment 1 terminated NCT00252759
Iressa Case Control Study in Japan No drug interventions Not Available Not Available completed NCT04960059
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts No drug interventions Not Available Not Available recruiting NCT03141359
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC treatment 2 active_not_recruiting NCT04401059
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study treatment 4 recruiting NCT02911259
Suction on Post-Operative Chest Tubes No drug interventions treatment Not Available completed NCT00490659
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes treatment 2 completed NCT03307759
Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma treatment 1 completed NCT03419559
Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer treatment 2 withdrawn NCT00642759
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03982459
National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC No drug interventions supportive_care Not Available completed NCT02659059
Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT03838159
NADIM II: Neo-Adjuvant Immunotherapy treatment 2 active_not_recruiting NCT01557959
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT05084859
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors treatment 1 terminated NCT00259675
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC treatment 2 completed NCT02491775
Afatinib Genomic Landscape No drug interventions Not Available Not Available terminated NCT04262375
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION treatment 2 withdrawn NCT02755675
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung No drug interventions Not Available 2 unknown_status NCT06331975
Radiomics and Radiogenomics of Non-small Cell Lung Cancer No drug interventions diagnostic Not Available completed NCT01139775
A Study in Non Small Cell Lung Cancer treatment 1 / 2 completed NCT01243775
BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC treatment 2 completed NCT00745875
ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study treatment 2 completed NCT03765775
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative treatment 2 unknown_status NCT04768075
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC treatment 3 unknown_status NCT00372775
Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases treatment 2 completed NCT00496275
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC treatment 1 completed NCT03358875
Comparison of Efficacy and Safety of Anti-PD-1 Antibody BGB-A317 Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With NSCLC treatment 3 completed NCT03150875
A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC treatment 3 completed NCT00883675
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer treatment 4 completed NCT04942275
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy No drug interventions other 2 / 3 unknown_status NCT06003075
Induction Chemo-Nivo in Unresectable Stage III NSCLC treatment 2 recruiting NCT01902875
Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy Not Available Not Available unknown_status NCT02273375
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC treatment 3 active_not_recruiting NCT04623775
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03460275
Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer treatment 2 unknown_status NCT04536675
Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery treatment 3 unknown_status NCT05132075
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT04213170
Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer treatment 2 unknown_status NCT03219970
Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting. Not Available Not Available completed NCT04640870
The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib Not Available Not Available completed NCT02146170
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors No drug interventions Not Available Not Available recruiting NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02007070
Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025) treatment 1 completed NCT06147570
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT01158170
Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) prevention 3 unknown_status NCT03704870
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection No drug interventions other 2 completed NCT00755170
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer treatment 2 completed NCT02961270
Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation treatment 2 unknown_status NCT05431270
Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor (the MORNINGSTAR Study) treatment 1 recruiting NCT02055170
Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer treatment 2 terminated NCT00977470
Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations treatment 2 unknown_status NCT04136470
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics Not Available Not Available unknown_status NCT00701870
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer supportive_care 2 terminated NCT04069442
cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors No drug interventions Not Available Not Available withdrawn NCT00459342
Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT00803842
Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash supportive_care Not Available withdrawn NCT06068842
A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants With Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05784142
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC) No drug interventions treatment 2 active_not_recruiting NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT06235242
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT00859742
Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC) No drug interventions diagnostic Not Available withdrawn NCT02604342
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib treatment 3 completed NCT03375242
Safety and Efficacy of Xalkori ROS1 Not Available Not Available recruiting NCT00234442
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer treatment 2 terminated NCT00419042
Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) Not Available Not Available completed NCT01789099
A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. treatment 1 / 2 unknown_status NCT02835599
Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now No drug interventions Not Available Not Available terminated NCT05520099
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT05013099
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies diagnostic 2 active_not_recruiting NCT03770299
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease treatment 2 withdrawn NCT03631199
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects treatment 3 active_not_recruiting NCT05603299
Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test No drug interventions diagnostic Not Available withdrawn NCT03713099
NEUWAVE Flexible Probe Study #2 No drug interventions treatment Not Available withdrawn NCT01828099
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer treatment 3 completed NCT02910999
Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy No drug interventions Not Available Not Available completed NCT04153799
Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT00491699
Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer treatment 1 terminated NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT03389399
Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases No drug interventions Not Available Not Available active_not_recruiting NCT02376699
Safety Study of SEA-CD40 in Cancer Patients treatment 1 terminated NCT02364999
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC treatment 3 completed NCT02573506
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer No drug interventions treatment 2 completed NCT00390806
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer treatment 3 completed NCT06248606
Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases treatment 2 recruiting NCT02764606
CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer Not Available Not Available recruiting NCT00409006
Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers treatment 2 completed NCT04923906
Aumolertinib With or Without Chemotherapy as 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Sensitizing EGFR Mutations treatment 3 recruiting NCT05937906
Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. treatment 1 / 2 not_yet_recruiting NCT03215706
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC treatment 3 active_not_recruiting NCT02275806
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC treatment 2 terminated NCT02013206
A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy treatment 2 completed NCT05880706
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT04722406
Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy. No drug interventions Not Available Not Available unknown_status NCT02651506
Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules No drug interventions diagnostic 2 withdrawn NCT05588206
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT03425006
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer treatment 2 terminated NCT05234606
A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors treatment 1 / 2 withdrawn NCT05255406
Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE) treatment 2 recruiting NCT05122806
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC No drug interventions basic_science Not Available recruiting NCT05507606
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations treatment 2 unknown_status NCT05949606
A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT01784549
Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease treatment 2 unknown_status NCT02681549
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT00423449
Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) treatment 1 completed NCT02442349
Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific treatment 2 active_not_recruiting NCT04706949
Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment treatment 2 unknown_status NCT00621049
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC treatment 2 completed NCT04758949
FL-101 in Surgically Resectable Non-Small Cell Lung Cancer treatment 2 withdrawn NCT06192849
To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy No drug interventions treatment 2 recruiting NCT02151149
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly treatment 4 completed NCT00318136
A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) treatment 2 completed NCT02980536
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China No drug interventions Not Available Not Available unknown_status NCT02273336
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer No drug interventions Not Available Not Available completed NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05754736
Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations. treatment 2 recruiting NCT03679936
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT02357836
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer treatment 0 completed NCT02495636
Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer treatment 2 withdrawn NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers No drug interventions Not Available Not Available recruiting NCT00192036
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer treatment 2 completed NCT02038413
State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of Patients No drug interventions Not Available Not Available completed NCT02475213
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer treatment 1 completed NCT04316013
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial other 3 recruiting NCT04795713
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 No drug interventions treatment 1 recruiting NCT03343613
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors No drug interventions treatment 1 terminated NCT04258813
Onco-primary Care Networking to Support TEAM-based Care No drug interventions prevention Not Available recruiting NCT03543813
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL No drug interventions treatment 1 / 2 completed NCT05617313
Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06071013
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients treatment 1 / 2 not_yet_recruiting NCT06554613
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC treatment 2 not_yet_recruiting NCT05244213
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC treatment 2 active_not_recruiting NCT04474613
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites No drug interventions diagnostic Not Available active_not_recruiting NCT00452413
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer treatment 1 / 2 completed NCT05979818
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer treatment 1 not_yet_recruiting NCT05751018
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT06124118
Tumor Treating Fields for Locally Advanced NSCLC treatment 1 recruiting NCT04965818
Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer treatment 1 terminated NCT05800418
Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers treatment 1 completed NCT02497118
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC treatment 4 completed NCT04198818
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors No drug interventions treatment 1 / 2 terminated NCT02507518
Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer No drug interventions other 2 unknown_status NCT02725918
Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure treatment 2 unknown_status NCT03599518
DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer treatment 1 terminated NCT01390818
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT02444819
Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy treatment 2 completed NCT00312819
Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer treatment 2 / 3 completed NCT00832819
E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03968419
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. treatment 2 terminated NCT03514719
PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE) diagnostic 1 completed NCT05900219
Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study treatment 2 not_yet_recruiting NCT05949619
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06530719
A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery treatment 2 not_yet_recruiting NCT05805319
Dietary Intervention for NSCLC Patients Treated With ICI No drug interventions treatment Not Available recruiting NCT01998919
A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. treatment 2 completed NCT03847519
Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01139619
A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) Patients No drug interventions Not Available Not Available completed NCT00099541
Non-small Cell Lung Cancer Registry treatment 4 completed NCT02651441
D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) treatment 1 / 2 unknown_status NCT00828841
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC treatment 2 completed NCT01968941
Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients No drug interventions treatment 3 completed NCT03427541
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases No drug interventions Not Available Not Available unknown_status NCT02353741
Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC No drug interventions treatment 2 terminated NCT03059641
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China No drug interventions Not Available Not Available completed NCT00540241
Performance Status During Treatment With Pemetrexed in Patients With NSCLC Not Available Not Available completed NCT05919641
LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT No drug interventions Not Available Not Available recruiting NCT00794417
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma treatment 1 / 2 terminated NCT03198117
Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC) No drug interventions prevention Not Available terminated NCT03900117
Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC No drug interventions treatment 2 completed NCT04322617
Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer treatment 2 / 3 recruiting NCT04941417
Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer Patients No drug interventions treatment 2 unknown_status NCT05551117
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors treatment 2 active_not_recruiting NCT00460317
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study treatment 3 terminated NCT01291017
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. treatment 2 completed NCT06364917
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC treatment 2 not_yet_recruiting NCT02804217
Acquired Resistant Mechanism of the First-generation EGFR TKIs No drug interventions Not Available Not Available unknown_status NCT06467617
Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC treatment 2 not_yet_recruiting NCT00832117
Phase I Combination Ixabepilone + Cisplatin treatment 1 completed NCT03764917
NGS Combined With RNAseq on Tumor Immune Escape in NSCLC No drug interventions Not Available Not Available unknown_status NCT04892017
A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors treatment 1 / 2 recruiting NCT02002117
Genotyping of Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05738317
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment treatment 2 recruiting NCT05426317
Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression No drug interventions other Not Available unknown_status NCT00997334
Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC treatment 2 completed NCT02584634
Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101) treatment 1 / 2 terminated NCT00762034
A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer treatment 3 completed NCT05425134
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer No drug interventions Not Available Not Available recruiting NCT02480634
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer treatment 4 unknown_status NCT06363734
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial treatment 2 recruiting NCT01813734
Ponatinib in Advanced NSCLC w/ RET Translocations treatment 2 completed NCT01625234
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04311034
A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT03689634
Move For Surgery - A Novel Preconditioning Program No drug interventions prevention 3 completed NCT05882734
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) treatment 1 / 2 recruiting NCT03982134
PDR001 + Panobinostat for Melanoma and NSCLC treatment 1 withdrawn NCT00862134
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05089734
Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT01066234
Adjuvant CCRT vs CT in Minimal N2 NSCLC No drug interventions treatment 2 completed NCT00321334
Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC No drug interventions treatment 3 completed NCT00758134
Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients treatment 2 terminated NCT05378334
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients No drug interventions treatment Not Available recruiting NCT03902834
Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery No drug interventions other Not Available completed NCT03800134
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT02540824
Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT01586624
A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) treatment 1 completed NCT02734524
A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer treatment 2 unknown_status NCT05786924
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers No drug interventions treatment 1 recruiting NCT04746924
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer treatment 3 active_not_recruiting NCT06300424
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC treatment 2 recruiting NCT03233724
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas treatment 1 / 2 terminated NCT00633724
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT05616624
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers treatment 1 / 2 recruiting NCT04581824
Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT06564324
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients treatment 3 not_yet_recruiting NCT01171924
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors treatment 1 completed NCT00173524
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available unknown_status NCT02452424
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors treatment 1 / 2 terminated NCT04939324
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT01398124
Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer No drug interventions treatment Not Available withdrawn NCT01099124
Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment Not Available completed NCT04905316
A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer treatment 2 active_not_recruiting NCT06370416
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib prevention 2 not_yet_recruiting NCT01924416
Lung Cancer Information Study (LCIS-R01) No drug interventions supportive_care Not Available completed NCT05383716
Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy treatment 2 active_not_recruiting NCT04879316
Energy for Lymphocytes No drug interventions Not Available Not Available completed NCT06382116
A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 recruiting NCT00246116
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer No drug interventions other Not Available completed NCT03267316
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors treatment 1 / 2 completed NCT06168916
AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer? No drug interventions Not Available Not Available completed NCT00113516
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT03710616
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals No drug interventions Not Available Not Available unknown_status NCT02387216
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC treatment 2 terminated NCT02015416
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer treatment 1 completed NCT06484816
TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies No drug interventions treatment 1 not_yet_recruiting NCT04025216
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers treatment 1 terminated NCT03750916
Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer treatment 2 unknown_status NCT00870116
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment Not Available unknown_status NCT02437916
Safety Study of AMG 228 to Treat Solid Tumors No drug interventions treatment 1 terminated NCT05314296
Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy No drug interventions Not Available Not Available unknown_status NCT01081496
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT04211896
Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer treatment 2 unknown_status NCT01000896
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel treatment 1 withdrawn NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) treatment 1 / 2 active_not_recruiting NCT02978196
99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC No drug interventions diagnostic 0 completed NCT01362296
An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer treatment 2 completed NCT00735696
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer treatment 2 completed NCT02001896
Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation treatment 3 unknown_status NCT06579196
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1 treatment 1 / 2 not_yet_recruiting NCT06557096
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC treatment 0 not_yet_recruiting NCT01570296
A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR treatment 1 completed NCT05060796
Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC No drug interventions treatment 0 recruiting NCT06516796
Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size No drug interventions Not Available Not Available completed NCT05860296
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers treatment 1 / 2 recruiting NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy No drug interventions treatment 1 / 2 completed NCT03774758
Biomarkers for Risk Stratification in Lung Cancer No drug interventions Not Available Not Available recruiting NCT04175158
Clinical Trial in Chinese Healthy Volunteers of GB222 treatment 1 unknown_status NCT02031458
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT05415358
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients No drug interventions Not Available Not Available recruiting NCT00674258
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT02067858
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System No drug interventions other Not Available terminated NCT00818558
The Method ISET (Insulation by Size of Epithelial Tumor Cells) No drug interventions prevention Not Available unknown_status NCT03519958
Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong No drug interventions Not Available Not Available withdrawn NCT01597258
Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed NCT02672358
Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC treatment 2 withdrawn NCT06082635
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT01383135
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 No drug interventions diagnostic 0 completed NCT05393635
ITIL-168 in Advanced Solid Tumors No drug interventions treatment 1 withdrawn NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours No drug interventions treatment 1 recruiting NCT00094835
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT01069835
Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN) No drug interventions Not Available Not Available completed NCT04556435
Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy No drug interventions Not Available Not Available terminated NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj. No drug interventions Not Available Not Available unknown_status NCT04440735
A Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT03953235
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens treatment 1 / 2 completed NCT01580735
ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer treatment 2 completed NCT05352035
Multiomics Tumor Evolution Model of NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04222335
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients No drug interventions treatment Not Available recruiting NCT06143735
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors No drug interventions treatment 2 not_yet_recruiting NCT04154163
Appropriate Dosing to Optimise Personalised Cancer Treatments No drug interventions Not Available Not Available completed NCT02679963
Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT03296163
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00364663
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00885963
A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer treatment 2 terminated NCT06287463
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway No drug interventions treatment 1 / 2 recruiting NCT01207063
Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 completed NCT01664663
Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy No drug interventions treatment 2 terminated NCT05337163
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China No drug interventions Not Available Not Available completed NCT00365963
Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers No drug interventions other 3 completed NCT06555263
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT04069663
Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study No drug interventions Not Available Not Available completed NCT00415363
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy treatment 2 completed NCT03068663
Microbiota and the Lung Cancer No drug interventions other Not Available recruiting NCT03535363
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC treatment 1 completed NCT03986463
CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility No drug interventions Not Available Not Available completed NCT06110663
A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy treatment 3 not_yet_recruiting NCT02562963
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT04789486
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer treatment 1 / 2 recruiting NCT01951586
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT01020786
A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients treatment 4 completed NCT03191786
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy treatment 3 completed NCT03196986
mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer treatment 3 completed NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 1-49% treatment 3 not_yet_recruiting NCT05319886
Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients Not Available Not Available recruiting NCT01263886
Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer treatment 2 completed NCT01270386
A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer treatment 2 completed NCT00179686
A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer treatment 2 completed NCT02617186
Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT No drug interventions treatment Not Available recruiting NCT03390686
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients treatment 3 active_not_recruiting NCT00418886
Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients treatment 3 completed NCT02284139
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects No drug interventions treatment 2 / 3 completed NCT05933239
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients No drug interventions diagnostic 2 recruiting NCT03101839
Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours No drug interventions treatment 1 completed NCT04793139
Efficacy and Safety of Camrelizumab in Real-World Prospective Study Not Available Not Available not_yet_recruiting NCT00085839
Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 treatment 2 completed NCT06568939
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT01687439
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05783622
Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT03257722
Pembrolizumab + Idelalisib for Lung Cancer Study treatment 1 / 2 terminated NCT06358222
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan No drug interventions Not Available Not Available recruiting NCT00356122
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00516022
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. No drug interventions treatment 2 completed NCT05469022
Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy treatment 2 recruiting NCT01407822
Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer treatment 2 / 3 unknown_status NCT00828022
Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT00686322
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) treatment 4 completed NCT04309422
Texture Features and PDL1 in CT-PET 18 FDG No drug interventions Not Available Not Available completed NCT00614822
Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT00572325
Concurrent Chemo-radiation Form NSCLC to a Individualized MLD No drug interventions Not Available Not Available completed NCT00446225
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR treatment 3 completed NCT03706625
Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment No drug interventions Not Available Not Available completed NCT02974725
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma treatment 1 terminated NCT00607425
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening No drug interventions Not Available Not Available terminated NCT04324125
Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT04159025
EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer No drug interventions diagnostic Not Available completed NCT05054725
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies treatment 2 active_not_recruiting NCT05825625
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing treatment 2 recruiting NCT04302025
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer treatment 2 recruiting NCT02760225
Pembrolizumab-PET Imaging No drug interventions diagnostic Not Available completed NCT05360225
Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit No drug interventions Not Available Not Available unknown_status NCT02132325
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer No drug interventions supportive_care Not Available completed NCT00216125
Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer treatment 3 completed NCT05176925
Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC treatment 2 terminated NCT00840125
Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment treatment 2 completed NCT00890825
AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients treatment 2 completed NCT01744925
Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR treatment 2 unknown_status NCT00373425
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors treatment 3 completed NCT02696525
Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT05538130
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors treatment 1 recruiting NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors treatment 1 / 2 active_not_recruiting NCT00862030
CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04895930
Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC treatment 2 recruiting NCT03088930
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer treatment 2 completed NCT06341530
Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT05925530
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) treatment 2 recruiting NCT01167530
Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer treatment 1 unknown_status NCT02542930
Abscopal Effect for Metastatic Non-small Cell Lung Cancer. treatment 2 withdrawn NCT03502330
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma treatment 1 completed NCT03486730
BT1718 in Patients With Advanced Solid Tumours. No drug interventions treatment 1 / 2 completed NCT04303130
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC treatment 2 unknown_status NCT02337530
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC treatment 2 completed NCT04297748
Bioimaging Study of 89Zr-M7824 in NSCLC treatment 1 / 2 terminated NCT06033248
Using Urine Samples to Identify Lung Cancer No drug interventions Not Available Not Available recruiting NCT05121948
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) No drug interventions treatment 1 terminated NCT00417248
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT00708448
Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients diagnostic 1 completed NCT04725448
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma treatment 2 unknown_status NCT05467748
EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT03087448
Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT01069757
A Study of ARQ 197 in Combination With Erlotinib treatment 1 completed NCT05141357
A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer treatment 2 terminated NCT06083857
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT02075957
Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03564457
20K Distributed Learning Challenge No drug interventions Not Available Not Available completed NCT00150657
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer treatment 2 unknown_status NCT00449657
Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC treatment 2 terminated NCT03485326
A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients No drug interventions Not Available Not Available completed NCT01998126
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer treatment 1 completed NCT02323126
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer treatment 2 terminated NCT05987826
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC treatment 2 not_yet_recruiting NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05276726
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1 treatment 1 / 2 recruiting NCT00442026
Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC treatment 3 terminated NCT00191126
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC treatment 3 completed NCT02752126
A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus No drug interventions supportive_care Not Available completed NCT03044626
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC treatment 2 completed NCT03451526
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01859026
A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation treatment 1 completed NCT02706626
Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors treatment 2 terminated NCT04397926
Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT00647426
Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC treatment 2 completed NCT05034926
A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus No drug interventions Not Available Not Available active_not_recruiting NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT02477826
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT01429766
A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients No drug interventions supportive_care 2 unknown_status NCT00380666
The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer No drug interventions treatment Not Available withdrawn NCT05168566
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT03444766
Study of Nivolumab for Advanced Cancers in India treatment 4 completed NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT02407366
Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer treatment 2 unknown_status NCT00847366
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma treatment Not Available completed NCT04911166
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy treatment 1 suspended NCT00998166
A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy treatment 2 terminated NCT06057766
Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03836066
Atezolizumab Plus Bevacizumab in First Line NSCLC Patients treatment 2 active_not_recruiting NCT00879866
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 completed NCT01052766
Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis No drug interventions treatment Not Available terminated NCT00363766
Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT00807066
Randomized Gefitinib Trial treatment 3 completed NCT05579366
PRO1184 for Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02824965
Pembrolizumab + CVA21 in Advanced NSCLC treatment 1 unknown_status NCT02470065
Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. treatment 2 suspended NCT00231465
Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT02590965
A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02576665
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) treatment 1 terminated NCT03614065
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC treatment 2 unknown_status NCT02043665
CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) treatment 1 completed NCT05480865
SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation treatment 1 recruiting NCT01562665
Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf No drug interventions Not Available Not Available completed NCT02498665
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies treatment 1 completed NCT03885765
Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping No drug interventions Not Available Not Available recruiting NCT01934465
Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment No drug interventions Not Available Not Available completed NCT00614965
Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV treatment 2 completed NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT04167774
A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC treatment 2 unknown_status NCT06394674
High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib treatment 2 recruiting NCT06219174
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) treatment 1 / 2 recruiting NCT05186974
Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT00051974
Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00050674
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma treatment 2 completed NCT06165874
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer No drug interventions diagnostic Not Available recruiting NCT04059874
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate treatment 1 unknown_status NCT05485974
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation No drug interventions treatment 1 recruiting NCT06277674
Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI treatment 2 recruiting NCT04415320
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases treatment 2 unknown_status NCT02005120
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC treatment 2 unknown_status NCT01652820
Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer treatment 2 completed NCT02646020
Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment treatment 2 completed NCT04732520
Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer No drug interventions treatment Not Available completed NCT01426620
Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT02308020
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain treatment 2 completed NCT05429320
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 recruiting NCT03574220
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer treatment 0 withdrawn NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT00343720
Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy treatment 2 completed NCT06146920
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation No drug interventions other Not Available recruiting NCT06569420
Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC No drug interventions treatment 3 active_not_recruiting NCT00667082
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma other 1 completed NCT04546282
Resistance to Oral Therapy in Lung Cancer No drug interventions Not Available Not Available completed NCT05254782
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection No drug interventions Not Available Not Available recruiting NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors treatment 1 terminated NCT01803282
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors treatment 1 completed NCT05860582
A Study of [14C]GB491 in Male Healthy Subjects No drug interventions treatment 1 completed NCT03001882
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00906282
Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer treatment 2 completed NCT01799382
Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens No drug interventions diagnostic Not Available completed NCT06099782
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11) treatment 2 recruiting NCT04036682
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer treatment 1 / 2 recruiting NCT05653882
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors treatment 1 recruiting NCT04880382
Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients No drug interventions treatment 2 active_not_recruiting NCT00362882
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT04526782
ENCOrafenib With Binimetinib in bRAF NSCLC treatment 2 recruiting NCT05956782
Breathe Easier II: A Dyad-based Multiple Behavior Intervention No drug interventions supportive_care Not Available completed NCT05029882
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab treatment 1 recruiting NCT01482182
Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy No drug interventions Not Available Not Available completed NCT01054482
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT02095782
Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation treatment 2 terminated NCT02152631
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer treatment 3 active_not_recruiting NCT00203931
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer treatment 2 terminated NCT03724331
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience No drug interventions other Not Available completed NCT02896231
First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001 treatment 1 completed NCT00103831
Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT00864331
Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy No drug interventions treatment 3 completed NCT02012231
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. treatment 1 terminated NCT04725331
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors treatment 1 / 2 recruiting NCT04165031
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation treatment 1 / 2 terminated NCT05240131
A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC). treatment 1 / 2 active_not_recruiting NCT04681131
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC treatment 2 recruiting NCT06542731
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT01812031
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease No drug interventions diagnostic Not Available completed NCT04591431
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy treatment 2 active_not_recruiting NCT03927573
Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker No drug interventions treatment 1 terminated NCT05982873
Expanded Access to ABBV-400 No drug interventions Not Available Not Available available NCT05601973
AMAZE-lung: Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI treatment 2 recruiting NCT04849273
A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC treatment 1 terminated NCT00550173
A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer treatment 2 completed NCT00050973
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 completed NCT00378573
Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT04909073
Observational Study of Afatinib 30 mg Daily Not Available Not Available recruiting NCT05384873
Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT05275673
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer treatment 2 terminated NCT04612673
A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC treatment 2 unknown_status NCT00372073
Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer treatment 2 terminated NCT06573073
Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation No drug interventions Not Available Not Available recruiting NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01168973
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy treatment 3 completed NCT02577627
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC No drug interventions Not Available Not Available unknown_status NCT03910127
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） treatment 1 unknown_status NCT01190527
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer No drug interventions treatment Not Available completed NCT05812027
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors No drug interventions Not Available Not Available recruiting NCT02538627
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib treatment 1 terminated NCT05068427
Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC. treatment 2 completed NCT03533127
A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer treatment 3 unknown_status NCT01212627
Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer treatment 1 terminated NCT02840227
The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections No drug interventions treatment Not Available withdrawn NCT02562027
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer No drug interventions health_services_research Not Available completed NCT06514027
Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations treatment 2 not_yet_recruiting NCT01533727
CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 withdrawn NCT06524427
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR) No drug interventions treatment Not Available recruiting NCT03656627
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease treatment 1 terminated NCT04682327
Gut Microbiota and Cancer Immunotherapy Response No drug interventions Not Available Not Available unknown_status NCT02949076
Skeletal Muscle Atrophy and Dysfunction in Human Cancer No drug interventions basic_science Not Available completed NCT04966676
Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer treatment 2 active_not_recruiting NCT01928576
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. treatment 2 completed NCT05546476
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 treatment 2 active_not_recruiting NCT05298176
Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors treatment 2 recruiting NCT04197076
Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB No drug interventions Not Available Not Available recruiting NCT02609776
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT00520676
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer treatment 3 completed NCT03818776
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC treatment 0 terminated NCT00190476
Elderly NSCLC/D vs DP (JCOG0207) treatment 3 terminated NCT06080776
SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations No drug interventions treatment 3 recruiting NCT04022876
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) treatment 1 terminated NCT02804776
PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery treatment 2 completed NCT01404260
Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer treatment 3 completed NCT01685060
LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib treatment 2 completed NCT06522360
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2) treatment 2 not_yet_recruiting NCT03658460
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers No drug interventions Not Available Not Available completed NCT06077760
A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) treatment 3 recruiting NCT00078260
A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer treatment 3 completed NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT00050960
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 completed NCT06341660
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. No drug interventions Not Available Not Available recruiting NCT06034860
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types treatment 1 recruiting NCT01391260
Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 unknown_status NCT05442060
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer prevention 2 recruiting NCT06275360
Repositioning Immunotherapy in VetArans With Lung Cancer treatment 2 recruiting NCT05418660
Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC Not Available Not Available recruiting NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT02879760
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients treatment 1 / 2 completed NCT00855894
A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer treatment 2 completed NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor Not Available Not Available available NCT05862194
Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC Not Available Not Available completed NCT00265694
Random Trial for Elderly Patients With NSCLC treatment 3 unknown_status NCT03646994
Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer Not Available Not Available recruiting NCT01823094
CTP Imaging of Lung Cancer No drug interventions Not Available Not Available completed NCT05284994
TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT03264794
the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) treatment 4 unknown_status NCT00333294
Phase II Iressa + Irradiation Followed by Chemo in NSCLC treatment 2 completed NCT03091491
Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer treatment 2 terminated NCT04161391
Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations No drug interventions treatment 1 / 2 terminated NCT01820091
Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn® prevention 1 withdrawn NCT04977791
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT01297491
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT03177291
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC treatment 1 active_not_recruiting NCT04322591
Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial No drug interventions Not Available Not Available recruiting NCT03560791
A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence No drug interventions Not Available Not Available completed NCT05955391
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 recruiting NCT03858491
Pharmacokinetic Boosting of Osimertinib treatment 0 completed NCT02905591
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC treatment 2 recruiting NCT05005091
Effect of Preoperative Oral Carbohydrate Administration in Thoracic Surgery Patients No drug interventions prevention Not Available completed NCT03195491
A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia treatment 3 completed NCT05445791
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations treatment 3 recruiting NCT05171062
Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer treatment 1 withdrawn NCT03289962
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors treatment 1 active_not_recruiting NCT04249362
Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy treatment 2 completed NCT03603262
Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC No drug interventions treatment 1 unknown_status NCT06305962
177Lu-anti-PD-L1 sdAb in Metastatic Non-small Cell Lung Cancer treatment 0 recruiting NCT01287962
Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer treatment 3 unknown_status NCT03188562
Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC. No drug interventions treatment Not Available completed NCT05619562
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients No drug interventions Not Available Not Available completed NCT05129462
Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients No drug interventions Not Available Not Available completed NCT00354562
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT00432562
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. treatment 1 completed NCT02365662
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor No drug interventions treatment 1 terminated NCT02417662
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT05926180
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients With EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) treatment 1 recruiting NCT05688280
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS No drug interventions treatment 1 / 2 recruiting NCT02391480
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer treatment 1 completed NCT00883480
Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma health_services_research Not Available completed NCT05637580
Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC No drug interventions Not Available Not Available completed NCT01871480
CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer treatment 2 terminated NCT03293680
Pembrolizumab in Elderly Patients With Advanced Lung Cancer treatment 2 completed NCT03289780
Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects No drug interventions Not Available Not Available active_not_recruiting NCT00956280
Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00970580
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer treatment 1 completed NCT00451880
Study of XL281 in Adults With Solid Tumors treatment 1 completed NCT02148380
Combination of Chemotherapy and Gefitinib as First-line Treatment treatment Not Available completed NCT00692380
Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC No drug interventions treatment 1 terminated NCT01893580
Perioperative Rehabilitation in Operation for Lung Cancer No drug interventions treatment Not Available terminated NCT01617980
Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer No drug interventions diagnostic Not Available terminated NCT00173680
Methylation Status of CD44 Promoter Region in Primary Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05424029
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT00277329
Study of XL999 in Patients With Non-small Cell Lung Cancer treatment 2 terminated NCT03514329
Vapor Ablation for Localized Cancer Lesions No drug interventions treatment Not Available not_yet_recruiting NCT06465329
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT03455829
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01837329
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer treatment 1 completed NCT04510129
A Multicenter Cancer Biospecimen Collection Study No drug interventions Not Available Not Available recruiting NCT04248829
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301) treatment 3 active_not_recruiting NCT03515629
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer treatment 3 terminated NCT06118229
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients No drug interventions Not Available Not Available recruiting NCT03870529
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer treatment 0 terminated NCT01707329
Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment treatment 2 unknown_status NCT05543629
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT06209229
Role of Neutrophils and Electro-bioluminescence in the Rehabilitation supportive_care 1 completed NCT01574729
Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma No drug interventions treatment 2 unknown_status NCT01456429
Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer. No drug interventions diagnostic Not Available active_not_recruiting NCT03138889
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 terminated NCT05775289
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06195189
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II treatment 1 / 2 recruiting NCT02973789
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) treatment 3 active_not_recruiting NCT02995889
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer No drug interventions diagnostic Not Available completed NCT02644889
EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment No drug interventions Not Available Not Available unknown_status NCT00581789
Erlotinib and Sunitinib in NSCLC treatment 1 completed NCT06084689
Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures treatment 2 not_yet_recruiting NCT05142189
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer treatment 1 recruiting NCT00297089
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT06171789
PRO1107 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04741789
Treatment Plan CINC280A02001M to Provide Access to Capmatinib, for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NSCLC) Not Available Not Available available NCT05913089
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer treatment 2 recruiting NCT01520389
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment treatment 1 completed NCT03998189
Metabolic and Microbial Profiling of Lung Cancer No drug interventions diagnostic Not Available terminated NCT02786589
Plasmodium Immunotherapy for Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT00399789
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04314089
Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) No drug interventions treatment 1 active_not_recruiting NCT01817192
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03306992
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study No drug interventions treatment 3 completed NCT00903292
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma screening Not Available unknown_status NCT03371992
Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC basic_science 0 unknown_status NCT03988192
Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response No drug interventions other Not Available terminated NCT05757492
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT03647592
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer Not Available Not Available recruiting NCT01836692
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study No drug interventions treatment Not Available completed NCT00704392
Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors treatment 1 withdrawn NCT01401192
Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression treatment 2 unknown_status NCT02309892
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC No drug interventions treatment 1 terminated NCT03875092
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study treatment 3 completed NCT00370292
Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02663492
Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients No drug interventions treatment Not Available unknown_status NCT05887492
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors treatment 1 / 2 recruiting NCT01158144
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) treatment 2 unknown_status NCT02055144
Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy No drug interventions Not Available Not Available unknown_status NCT05154344
RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU) Not Available Not Available completed NCT05094544
Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC No drug interventions treatment Not Available recruiting NCT02031744
A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer treatment 3 completed NCT01026844
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05145244
Copenhagen Master Observational Trial No drug interventions Not Available Not Available unknown_status NCT01201044
Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC) treatment Not Available unknown_status NCT06564844
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features treatment 3 not_yet_recruiting NCT03002844
EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism treatment 2 unknown_status NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies treatment 1 recruiting NCT03953144
Synapse 3D With Intravascular Indocyanine Green treatment 1 / 2 recruiting NCT03628144
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer No drug interventions supportive_care 2 withdrawn NCT03754244
A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics No drug interventions treatment 1 terminated NCT05277844
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC No drug interventions treatment 2 recruiting NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT03202940
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC treatment 1 / 2 active_not_recruiting NCT01061840
Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer No drug interventions treatment 1 completed NCT05221840
A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer treatment 3 recruiting NCT01100840
A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT06434740
A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC No drug interventions treatment 2 not_yet_recruiting NCT03958240
Deciphering Mechanisms Underlying Cancer Immunogenicity No drug interventions other Not Available recruiting NCT03872440
PDX Models From EGFR Mutant Tumors No drug interventions Not Available Not Available withdrawn NCT03088540
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT02075840
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants treatment 3 active_not_recruiting NCT06582940
Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis No drug interventions treatment 2 recruiting NCT04678440
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients No drug interventions basic_science 0 enrolling_by_invitation NCT01507740
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients Not Available Not Available terminated NCT05800340
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC treatment 2 recruiting NCT00680940
A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT03833440
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance treatment 2 active_not_recruiting NCT02802540
Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients treatment 2 / 3 unknown_status NCT05745740
A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation treatment 1 / 2 not_yet_recruiting NCT01069640
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT00441740
Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer treatment 3 completed NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers treatment 1 / 2 withdrawn NCT03613467
Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients No drug interventions Not Available Not Available completed NCT03427567
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01647867
Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers No drug interventions basic_science Not Available completed NCT02708667
An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT05872867
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) treatment 1 recruiting NCT00198367
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT02777567
KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy) No drug interventions Not Available Not Available completed NCT05584267
Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy No drug interventions treatment 2 recruiting NCT05837767
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue No drug interventions treatment Not Available recruiting NCT01913067
Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC treatment 2 withdrawn NCT05094167
Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients No drug interventions prevention Not Available unknown_status NCT03661567
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer treatment 2 terminated NCT02998567
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab health_services_research 1 recruiting NCT02189967
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation No drug interventions treatment Not Available completed NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT00243867
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer treatment 3 completed NCT06424067
Phase 2 Study of Fingolimod in Lung Cancers treatment 2 not_yet_recruiting NCT04332367
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance treatment 2 recruiting NCT04731467
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT02833467
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA No drug interventions Not Available Not Available unknown_status NCT00749567
Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer treatment 2 terminated NCT05805267
To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC No drug interventions Not Available Not Available completed NCT01949701
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT02927301
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3) treatment 2 completed NCT00875901
Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03) No drug interventions treatment Not Available completed NCT02731001
Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer No drug interventions treatment Not Available recruiting NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. treatment 1 recruiting NCT05537701
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study) No drug interventions Not Available Not Available active_not_recruiting NCT02737501
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants treatment 3 completed NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer treatment 1 / 2 active_not_recruiting NCT01888601
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx) No drug interventions Not Available Not Available active_not_recruiting NCT02186301
TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy treatment 2 / 3 terminated NCT01004601
Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer treatment Not Available completed NCT01297101
Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy Not Available Not Available temporarily_not_available NCT00712504
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer treatment 1 completed NCT06567704
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study No drug interventions Not Available Not Available not_yet_recruiting NCT04985604
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors treatment 1 / 2 recruiting NCT04500704
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC treatment 3 unknown_status NCT03789604
A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT06192004
Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD No drug interventions Not Available Not Available recruiting NCT01560104
A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT00609804
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib treatment 2 completed NCT04547504
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 % treatment 3 active_not_recruiting NCT06225804
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT00862004
Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT06224504
Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione No drug interventions supportive_care Not Available completed NCT00102804
Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02575404
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients treatment 1 completed NCT05094804
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT00707304
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer treatment 3 completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT00455572
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer treatment 1 terminated NCT05815472
Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT) No drug interventions diagnostic Not Available recruiting NCT01565772
Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer treatment 1 terminated NCT00702572
Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT05716672
Impact of Lazertinib Dose Modification on Effectiveness and Safety Not Available Not Available not_yet_recruiting NCT03311672
T-Cell PET Imaging With [18F]F-AraG in Lung Cancer diagnostic 2 withdrawn NCT05730972
TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer No drug interventions treatment Not Available not_yet_recruiting NCT02127372
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 treatment 1 / 2 terminated NCT03322072
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating No drug interventions treatment Not Available active_not_recruiting NCT01749072
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients treatment 2 unknown_status NCT04937972
SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma treatment 2 recruiting NCT03416972
Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy No drug interventions Not Available Not Available unknown_status NCT04622072
XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer No drug interventions treatment 1 terminated NCT04480372
SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II treatment 2 completed NCT03944772
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) treatment 2 active_not_recruiting NCT04206072
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC treatment 2 / 3 active_not_recruiting NCT02504372
Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) treatment 3 active_not_recruiting NCT01947868
Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor No drug interventions Not Available Not Available completed NCT02318368
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label treatment 2 terminated NCT02409368
An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC other 2 completed NCT04187768
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT03228368
The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients Not Available Not Available unknown_status NCT03965468
Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC No drug interventions treatment 2 recruiting NCT02492568
Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC treatment 2 completed NCT02105168
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment No drug interventions screening Not Available unknown_status NCT03198468
Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) No drug interventions treatment Not Available completed NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT04699968
A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC treatment 2 withdrawn NCT02843568
Improving Pulmonary Function Following Radiation Therapy No drug interventions treatment Not Available active_not_recruiting NCT01189968
A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer treatment 1 completed NCT03849768
A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients treatment 3 active_not_recruiting NCT03003468
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017 treatment 1 / 2 completed NCT01356368
Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT01380769
A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00221169
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer No drug interventions diagnostic 0 completed NCT02523469
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03195569
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer Not Available Not Available unknown_status NCT03094169
AVID100 in Advanced Epithelial Carcinomas No drug interventions treatment 1 / 2 terminated NCT05811169
Quest for Tumour Evolution of Non-small Cell Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02431169
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression No drug interventions Not Available Not Available terminated NCT01951469
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer treatment 3 unknown_status NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT03490669
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors No drug interventions treatment 1 completed NCT00819169
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors treatment 1 / 2 terminated NCT04504669
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours treatment 1 active_not_recruiting NCT05703269
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy No drug interventions supportive_care Not Available recruiting NCT03399669
The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation treatment 2 unknown_status NCT05020769
SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer. treatment 2 / 3 recruiting NCT00722969
Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer treatment 2 unknown_status NCT01179269
Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer treatment 2 withdrawn NCT03836469
Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil No drug interventions Not Available Not Available completed NCT03940846
CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology No drug interventions Not Available Not Available unknown_status NCT06288646
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer No drug interventions Not Available Not Available terminated NCT05669846
Responder-derived FMT (R-FMT) and Pembrolizumab in Relapsed/Refractory PD-L1 Positive NSCLC treatment 2 not_yet_recruiting NCT00762346
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis treatment 4 completed NCT00714246
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT04345146
Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC treatment 2 completed NCT06422546
A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC No drug interventions Not Available Not Available recruiting NCT04384146
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 active_not_recruiting NCT01427946
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer treatment 1 / 2 completed NCT00034346
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT06163846
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence. No drug interventions Not Available Not Available recruiting NCT05990946
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer No drug interventions supportive_care Not Available recruiting NCT01525446
Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer No drug interventions treatment 0 terminated NCT05555212
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation No drug interventions treatment 1 recruiting NCT01040312
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Not Available Not Available completed NCT05369312
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients No drug interventions treatment 1 not_yet_recruiting NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) treatment 1 recruiting NCT06448312
A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT01222312
Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel treatment 2 completed NCT01124812
131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 terminated NCT04870112
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer treatment 1 terminated NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers No drug interventions supportive_care 3 completed NCT05257512
Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT03951012
Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy No drug interventions Not Available Not Available terminated NCT01327612
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) treatment 2 completed NCT00556712
A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT04806412
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study. No drug interventions diagnostic Not Available unknown_status NCT00347412
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer treatment 3 completed NCT01028612
Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size No drug interventions treatment Not Available terminated NCT02963610
Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT05082610
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab treatment 1 recruiting NCT05074810
Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients treatment 1 / 2 recruiting NCT05671510
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors treatment 3 recruiting NCT03825510
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect No drug interventions treatment 2 completed NCT03999710
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT03215810
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT00864110
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic 1 completed NCT05015010
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC treatment 2 active_not_recruiting NCT00949910
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 4 completed NCT03345810
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) treatment 2 completed NCT00461110
A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) treatment 1 terminated NCT02082210
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer treatment 1 / 2 completed NCT05450081
Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in Patients No drug interventions Not Available Not Available completed NCT01106781
A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology No drug interventions Not Available Not Available completed NCT04698681
NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial No drug interventions Not Available Not Available terminated NCT06369181
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC No drug interventions Not Available Not Available recruiting NCT03130881
Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC. No drug interventions treatment 1 unknown_status NCT03917381
GEN1046 Safety Trial in Patients With Malignant Solid Tumors treatment 1 / 2 active_not_recruiting NCT03758781
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors treatment 1 completed NCT04849481
The Research Plan of Taiwan Precision Medicine No drug interventions Not Available Not Available recruiting NCT01728181
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation treatment 1 / 2 withdrawn NCT02322281
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy treatment 3 terminated NCT01511081
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) No drug interventions treatment 2 terminated NCT00246181
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC No drug interventions treatment 1 / 2 completed NCT05746481
Carboplatin, Pemetrexed, and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases treatment 2 recruiting NCT05256381
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors treatment 2 active_not_recruiting NCT06311981
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients No drug interventions treatment 2 recruiting NCT05170581
Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer treatment 2 recruiting NCT05460481
Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors treatment 2 recruiting NCT05552781
H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC No drug interventions treatment 1 / 2 recruiting NCT04758481
Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT04889495
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer Not Available Not Available not_yet_recruiting NCT01887795
Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study treatment 3 completed NCT06046495
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT01066195
Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy treatment 3 unknown_status NCT00741195
Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer treatment 2 completed NCT01770795
A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer treatment 2 completed NCT01593995
EGF Ointment for Erlotinib Skin Lesion No drug interventions treatment 2 completed NCT00200395
OSI-774 (Erlotinib, Tarceva) in Elderly Patients treatment 2 completed NCT05462795
Liquid Biopsy for Early Non-small Lung Cancer Detection No drug interventions Not Available Not Available active_not_recruiting NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT00517595
Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC treatment 2 completed NCT05254795
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care No drug interventions other Not Available recruiting NCT00482014
A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer treatment 1 / 2 completed NCT06439914
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy diagnostic 1 not_yet_recruiting NCT00440414
Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00576914
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer treatment 3 unknown_status NCT01185314
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions screening Not Available completed NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications treatment 1 recruiting NCT03639714
A Study of a Personalized Neoantigen Cancer Vaccine treatment 1 / 2 completed NCT05024214
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors treatment 1 / 2 recruiting NCT01172314
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients No drug interventions other Not Available unknown_status NCT02771314
Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC other 2 unknown_status NCT05229614
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease treatment 2 recruiting NCT02720614
Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT02770014
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer treatment 2 terminated NCT02381314
Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer treatment 1 completed NCT05136014
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model No drug interventions Not Available Not Available unknown_status NCT06218914
A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation No drug interventions treatment 1 recruiting NCT00097214
Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02758314
Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study No drug interventions Not Available Not Available recruiting NCT02202655
Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT01982955
Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) treatment 1 / 2 completed NCT06477055
The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer treatment 2 not_yet_recruiting NCT03373955
A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients Not Available Not Available unknown_status NCT01104155
Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02136355
A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer No drug interventions treatment Not Available completed NCT03689855
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC treatment 2 completed NCT00958555
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00599755
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) diagnostic 1 completed NCT02513355
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research treatment 4 unknown_status NCT05034055
Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer treatment 2 unknown_status NCT01646450
First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients treatment 4 unknown_status NCT02595450
A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer Not Available Not Available completed NCT01004250
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer treatment 2 completed NCT05472350
Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy treatment Not Available unknown_status NCT00359450
Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) treatment 2 terminated NCT06331650
A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer treatment 2 recruiting NCT03553550
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation No drug interventions Not Available Not Available terminated NCT02488850
Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC No drug interventions basic_science Not Available recruiting NCT03674450
Lung Heart Rate Variability No drug interventions treatment Not Available withdrawn NCT04828850
Preoperative Lymph Node Staging With EBUS-TBNA in Clinical N0 Non Small-cell Lung Cancer No drug interventions diagnostic Not Available unknown_status NCT02695550
Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT02292550
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer. treatment 1 completed NCT00685750
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma No drug interventions screening Not Available terminated NCT05486650
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment No drug interventions Not Available Not Available recruiting NCT04029350
Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M treatment 2 unknown_status NCT04037150
Circulating DNA in Surgically Treated NSCLC No drug interventions Not Available Not Available unknown_status NCT00655850
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT01156623
Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic Country No drug interventions diagnostic Not Available completed NCT03852823
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours No drug interventions treatment 1 unknown_status NCT04748523
Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia treatment Not Available completed NCT01755923
Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC treatment 2 unknown_status NCT01170923
FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer No drug interventions diagnostic 2 unknown_status NCT03644823
Combinatory ImmunoTherapy-1 (Com-IT-1) Irradiation and PD-1 Blockade in Locally Advanced / Advanced NSCLC treatment 2 terminated NCT05414123
A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide No drug interventions Not Available Not Available terminated NCT01967823
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer treatment 2 completed NCT03083808
Phase II Trial of Continuation Therapy in Advanced NSCLC treatment 2 completed NCT01639508
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity treatment 2 recruiting NCT06228508
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA) No drug interventions Not Available Not Available not_yet_recruiting NCT03527108
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC treatment 2 recruiting NCT02340208
A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 No drug interventions treatment 1 / 2 completed NCT06406608
Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT01860508
A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers treatment Not Available unknown_status NCT05015608
Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification treatment 3 recruiting NCT04312308
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT05781308
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy treatment 2 recruiting NCT03840408
Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT01714908
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 No drug interventions treatment 2 unknown_status NCT01891708
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT04675008
Central Nervous System(CNS) Efficacy of Dacomitinib treatment 2 unknown_status NCT01260038
Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium. No drug interventions Not Available Not Available completed NCT05007938
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer treatment 2 active_not_recruiting NCT00743938
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC treatment 2 completed NCT05117138
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors No drug interventions treatment 1 / 2 unknown_status NCT04455438
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions No drug interventions treatment Not Available recruiting NCT04981938
Pulmonary Function After Arterial Sleeve Lobectomy No drug interventions Not Available Not Available completed NCT04304638
Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC No drug interventions Not Available Not Available unknown_status NCT02274038
Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT05925738
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05374538
VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer treatment 1 terminated NCT06330038
Anesthesia and Non-small Cell Lung Cancer Recurrence prevention 4 not_yet_recruiting NCT04131543
Phase II Study With Cabozantinib in Patients With RET Positive NSCLC treatment 2 unknown_status NCT03798743
Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study treatment 2 completed NCT06091943
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer treatment 1 recruiting NCT01192243
Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients treatment 2 unknown_status NCT03615443
Noninvasive vs. Invasive Lung Evaluation No drug interventions Not Available Not Available completed NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT03917043
APG-2449 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02883543
First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation treatment 3 unknown_status NCT02367443
Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC No drug interventions treatment 1 / 2 unknown_status NCT01465243
Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose treatment 4 completed NCT02455843
Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC No drug interventions treatment 3 unknown_status NCT00690703
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation No drug interventions treatment 2 completed NCT03940703
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) treatment 2 active_not_recruiting NCT02895503
Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment No drug interventions supportive_care Not Available terminated NCT00694603
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy treatment 2 terminated NCT00372203
Endobronchial Ultrasound vs Mediastinoscopy in NSCLC No drug interventions diagnostic 2 completed NCT05379803
High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases treatment 2 recruiting NCT02450903
LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. treatment 2 completed NCT05513703
A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03991403
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC treatment 3 active_not_recruiting NCT05291403
Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion No drug interventions treatment Not Available recruiting NCT00068003
Harvesting Cells for Experimental Cancer Treatments No drug interventions Not Available Not Available enrolling_by_invitation NCT04809103
Intratumoral Cisplatin for Resectable NSCLC treatment 1 unknown_status NCT02803203
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers treatment 1 / 2 completed NCT03740503
Genomic Investigation of Unusual Responders No drug interventions Not Available Not Available recruiting NCT00216203
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer treatment 1 / 2 completed NCT00265603
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer No drug interventions treatment 1 terminated NCT06422403
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers No drug interventions treatment 2 not_yet_recruiting NCT00871403
Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer treatment 2 completed NCT01256203
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light No drug interventions prevention 2 withdrawn NCT01872403
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung treatment 2 unknown_status NCT00918203
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04263090
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment treatment 1 / 2 completed NCT02835690
Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032) treatment 1 completed NCT01951690
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer treatment 2 completed NCT04585490
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC treatment 3 recruiting NCT04650490
SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer No drug interventions treatment 2 withdrawn NCT03735290
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer treatment 1 terminated NCT05098990
Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC treatment 4 unknown_status NCT01531790
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients treatment 1 completed NCT01946490
Time Trends in Waiting Times of NSCLC Patients. No drug interventions Not Available Not Available withdrawn NCT05256290
Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations No drug interventions treatment 1 / 2 recruiting NCT02368990
T790M Mutation Positive 2nd Line STandard of cAre Registry No drug interventions Not Available Not Available withdrawn NCT04490564
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma No drug interventions Not Available Not Available active_not_recruiting NCT06281964
Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion. No drug interventions treatment 3 not_yet_recruiting NCT03065764
89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer diagnostic 2 unknown_status NCT03936764
Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection Surgery No drug interventions supportive_care Not Available completed NCT04316364
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC treatment 3 recruiting NCT01159964
Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery No drug interventions treatment 1 terminated NCT05361564
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions. treatment 2 unknown_status NCT06448364
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination treatment 1 active_not_recruiting NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05858164
A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors No drug interventions basic_science 1 recruiting NCT00858364
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy supportive_care 3 terminated NCT00678964
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT05278364
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT03735264
Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034） treatment 2 unknown_status NCT04324164
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT04867564
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy No drug interventions Not Available Not Available unknown_status NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers treatment 1 / 2 recruiting NCT06150664
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT05932264
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT02702921
Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies No drug interventions treatment Not Available completed NCT04676321
Key Performance Indicators for the Assessment of NSCLC Patients Pathway No drug interventions Not Available Not Available completed NCT00606021
A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT01165021
A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer treatment 2 completed NCT01945021
Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC treatment 2 completed NCT05741021
A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT03042221
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy No drug interventions Not Available Not Available recruiting NCT05577702
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer treatment 2 recruiting NCT04968002
Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy treatment 2 / 3 unknown_status NCT01058902
The Effect Of Aspirin On Survival in Lung Cancer treatment 3 withdrawn NCT04957602
Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells) No drug interventions Not Available Not Available terminated NCT05712902
DZD9008 in Pretreated Lung Cancer Patients With EGFR Exon20 Insertion Mutation treatment 2 active_not_recruiting NCT01454102
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) treatment 1 completed NCT05430802
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIIA-IIIB Resectable NSCLC (FORESEE) treatment 2 recruiting NCT01502202
Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers treatment 2 unknown_status NCT05935384
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation No drug interventions Not Available Not Available recruiting NCT03631784
A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799) treatment 2 completed NCT00986284
Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC) treatment 2 suspended NCT00531284
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma treatment 1 / 2 completed NCT03123484
β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC treatment 2 unknown_status NCT03471884
Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection No drug interventions treatment Not Available unknown_status NCT05254184
KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC treatment 1 recruiting NCT01745484
Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation No drug interventions treatment Not Available completed NCT00563784
TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT01355484
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT05375084
SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation treatment 1 recruiting NCT01840579
Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) treatment 1 completed NCT01792479
A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer No drug interventions treatment 2 completed NCT02135679
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy No drug interventions Not Available Not Available active_not_recruiting NCT00120679
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy treatment 2 completed NCT04189679
Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma No drug interventions Not Available Not Available completed NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis treatment 1 / 2 recruiting NCT00743379
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors treatment 1 / 2 completed NCT01836679
Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer treatment 2 completed NCT04964479
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) treatment 3 unknown_status NCT02968979
Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer. No drug interventions Not Available Not Available completed NCT01405079
Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation treatment 3 unknown_status NCT04895579
Lung Cancer With Copanlisib and Durvalumab treatment 1 active_not_recruiting NCT00099879
Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer treatment 2 terminated NCT04123379
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) treatment 2 completed NCT05360979
A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC treatment 2 enrolling_by_invitation NCT05011487
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC treatment 2 recruiting NCT01184287
A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer treatment 2 withdrawn NCT05800587
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer treatment 2 recruiting NCT00343187
A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash treatment 2 terminated NCT03819387
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer No drug interventions treatment 1 completed NCT06224387
CTS2190 Phase I /II Clinical Study in Patients No drug interventions treatment 1 / 2 recruiting NCT06379087
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC treatment 2 not_yet_recruiting NCT04553887
Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial treatment 2 unknown_status NCT04912687
Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients No drug interventions screening Not Available recruiting NCT02572687
A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies treatment 1 completed NCT06557187
Hippocampus-Avoidance Whole-Brain Radiation Therapy With Simultaneous Integrated Boost for BMs of NSCLC No drug interventions treatment Not Available completed NCT05348187
Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit No drug interventions diagnostic Not Available unknown_status NCT00048087
Iressa/Docetaxel in Non-Small-Cell Lung Cancer treatment 2 withdrawn NCT03758287
Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative treatment 1 / 2 unknown_status NCT04430933
A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC treatment 1 / 2 withdrawn NCT03086733
Phase II Lung Metcore - Preoperative Metformin for Lung Cancer treatment 2 completed NCT03699033
Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer treatment 2 withdrawn NCT00697333
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC No drug interventions treatment 2 unknown_status NCT02544633
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET treatment 2 completed NCT01522833
Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer No drug interventions Not Available Not Available completed NCT06293833
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan No drug interventions screening Not Available enrolling_by_invitation NCT00826033
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer No drug interventions Not Available Not Available completed NCT04596033
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy treatment 1 terminated NCT03951233
K-RAS and EGFR in Lung Cancer No drug interventions Not Available Not Available completed NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations treatment 3 recruiting NCT02972333
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M treatment 3 unknown_status NCT00456833
Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy treatment 1 completed NCT01017133
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer No drug interventions diagnostic 1 completed NCT02289833
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03392233
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors No drug interventions treatment 2 recruiting NCT03612154
Study of Lorlatinib in ROS1 Rearranged NSCLC treatment 2 unknown_status NCT01607554
Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT06440954
Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases treatment 2 recruiting NCT03564054
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction No drug interventions treatment Not Available terminated NCT03267654
Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance treatment 2 unknown_status NCT03271554
Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea Not Available Not Available completed NCT06123754
Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC treatment 3 recruiting NCT01360554
ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT01820754
Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05654454
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer treatment 3 recruiting NCT06249854
Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT03166254
Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer treatment 1 withdrawn NCT03804554
A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab No drug interventions Not Available Not Available completed NCT06448754
Volrustomig Priming Regimens Exploratory Phase II Platform Study treatment 2 not_yet_recruiting NCT01287754
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations treatment 4 completed NCT02486354
Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy treatment 3 completed NCT05012254
Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases treatment 2 active_not_recruiting NCT03551951
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow No drug interventions Not Available Not Available recruiting NCT04541251
Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC treatment 2 unknown_status NCT04326751
Evolution of Multiple Primary Lung Cancer (Evolution) No drug interventions Not Available Not Available unknown_status NCT01963351
Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC No drug interventions Not Available Not Available completed NCT05167851
The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT05634551
Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status No drug interventions Not Available Not Available completed NCT06333951
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) treatment 1 recruiting NCT03743051
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02848651
A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT03915951
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT02991651
Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC treatment 1 suspended NCT01990651
Study of Use of CTC in NSCLC No drug interventions Not Available Not Available unknown_status NCT05059951
Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer No drug interventions Not Available Not Available recruiting NCT00364351
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy treatment 3 completed NCT03454451
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers treatment 1 completed NCT03791151
Pharmacogenetics in Non Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT01746251
Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation treatment 2 unknown_status NCT00073151
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT02109653
Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC treatment 2 withdrawn NCT01194453
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT01124253
Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) treatment 3 completed NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors treatment 1 / 2 recruiting NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT01450553
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease No drug interventions Not Available Not Available unknown_status NCT05237453
Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT00771953
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer treatment 2 completed NCT04772053
Molecular Disease Characterization Initiative (MDCI) No drug interventions other 2 terminated NCT04495153
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC treatment 2 active_not_recruiting NCT03099577
PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer No drug interventions treatment Not Available completed NCT00312377
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer treatment 3 completed NCT02859077
EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism treatment 3 unknown_status NCT00673777
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT00678977
A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors treatment 1 completed NCT02592577
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC No drug interventions treatment 1 completed NCT04395677
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene treatment 2 active_not_recruiting NCT05400577
Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC treatment 2 withdrawn NCT01074177
Understanding Mechanisms of Acquired Resistance to BIBW2992 treatment Not Available completed NCT05576077
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04585477
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) treatment 2 recruiting NCT03758677
Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation treatment 2 unknown_status NCT01746277
Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy treatment 2 unknown_status NCT06528847
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma treatment 2 recruiting NCT01649947
Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II treatment 2 completed NCT01466647
A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) treatment 1 completed NCT06574347
Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC. treatment 2 recruiting NCT00794547
Phase I/II Calcitriol in Lung Cancer treatment 1 / 2 terminated NCT02405247
TAURAS - T790 AURA ScreenFailure SOC Registry Study No drug interventions Not Available Not Available terminated NCT02658747
Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK No drug interventions Not Available Not Available completed NCT04948047
Breath Combined With CT for Diagnoses of Pulmonary Nodules No drug interventions Not Available Not Available unknown_status NCT04740047
Cios Mobile 3D Spin for Robotic Bronchoscopy No drug interventions Not Available Not Available completed NCT02197247
Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC other 1 completed NCT04695847
M1231 in Participants With Solid Tumors No drug interventions treatment 1 completed NCT00369447
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT00717847
A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib No drug interventions Not Available Not Available completed NCT02730247
Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02789345
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer treatment 1 completed NCT04881045
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. No drug interventions treatment 1 completed NCT01633645
Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT03123445
Endostar First-line Treatment of Advanced NSCLC treatment 2 unknown_status NCT05922345
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. No drug interventions treatment 3 recruiting NCT00830245
A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer treatment 2 terminated NCT02374645
A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC treatment 1 completed NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer treatment 1 terminated NCT01763645
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer treatment 3 completed NCT01156545
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC treatment 2 completed NCT05778045
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences No drug interventions Not Available Not Available not_yet_recruiting NCT05746598
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients Not Available Not Available recruiting NCT03647098
Analysis of Survival Status of KRAS Mutation Advanced Non-small Cell Lung Cancer Not Available Not Available recruiting NCT00750698
A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib treatment 2 terminated NCT04580498
A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC treatment 2 active_not_recruiting NCT01027598
Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer treatment 2 completed NCT01019798
Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer treatment 2 unknown_status NCT03504098
Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT00985998
Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer treatment 1 withdrawn NCT01279798
Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L) No drug interventions Not Available Not Available no_longer_available NCT03656705
CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma No drug interventions treatment 1 completed NCT02299505
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03244605
Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients No drug interventions treatment 3 unknown_status NCT06304805
TGRX-326 Phase I/II Pharmacokinetic Study treatment 1 completed NCT02042105
A Prospective Epidemiologic Study of ALK-Positive NSCLC in China No drug interventions Not Available Not Available completed NCT00271505
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer treatment 2 completed NCT06303505
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC No drug interventions treatment 1 / 2 recruiting NCT01510405
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04803305
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia treatment 1 completed NCT00982605
EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN) No drug interventions Not Available Not Available unknown_status NCT02666105
Exemestane in Post-Menopausal Women With NSCLC treatment 2 completed NCT04501497
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) No drug interventions Not Available Not Available completed NCT01772797
Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer treatment 1 completed NCT06537297
Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases treatment 2 not_yet_recruiting NCT06285097
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors treatment 1 recruiting NCT03922997
A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 completed NCT02037997
Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC treatment 2 unknown_status NCT01355497
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum treatment 3 completed NCT02730897
Multicentric Analysis of Predictors of N1 Upstaging After Resection of cStage-I NSCLC No drug interventions Not Available Not Available completed NCT03474497
UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade treatment 1 / 2 recruiting NCT01783197
Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC treatment 1 completed NCT05891197
A Biomarker Screening Protocol for Participants With Solid Tumors No drug interventions Not Available Not Available recruiting NCT00994097
NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT01471197
Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer treatment 2 terminated NCT04914897
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) treatment 2 active_not_recruiting NCT03790397
Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive Not Available Not Available completed NCT02448797
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation treatment 3 unknown_status NCT00219297
Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer treatment 2 completed NCT01136083
Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients No drug interventions treatment Not Available completed NCT05341583
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer treatment 3 recruiting NCT01048983
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) supportive_care 1 / 2 withdrawn NCT02852083
A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC treatment 2 unknown_status NCT00410683
Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery No drug interventions treatment 3 unknown_status NCT00489983
Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy treatment 2 completed NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors treatment 1 recruiting NCT02338583
Powered Surgical Stapler in VATS Lung Resection Procedures in China No drug interventions Not Available Not Available completed NCT00413283
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) supportive_care 2 completed NCT04818983
The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) No drug interventions Not Available Not Available completed NCT00582283
NM404 as an Imaging Agent in Patients With NSCLC No drug interventions diagnostic 1 completed NCT00887783
Navelbine And Radiotherapy in Locally Advanced Lung Cancer treatment 2 completed NCT02788461
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy No drug interventions treatment Not Available active_not_recruiting NCT02684461
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel treatment 2 completed NCT02125461
A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer treatment 3 completed NCT06511661
Prognostic Significance of the Uncertain Resection in NSCLC No drug interventions Not Available Not Available active_not_recruiting NCT05782361
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC health_services_research 1 recruiting NCT02481661
Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC No drug interventions treatment 3 unknown_status NCT01918761
Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT04698161
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases No drug interventions Not Available Not Available completed NCT03301961
Multiplex Analysis of Circulating Tumor DNA No drug interventions Not Available Not Available unknown_status NCT02360761
Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy No drug interventions treatment 3 unknown_status NCT04999761
AB122 Platform Study treatment 1 recruiting NCT02094261
Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours treatment 2 completed NCT06294561
TGRX-326 Pharmacokinetic Drug Interaction treatment 1 completed NCT02537561
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors treatment 1 withdrawn NCT00995761
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02336061
Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer No drug interventions Not Available Not Available terminated NCT01023828
K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications No drug interventions Not Available Not Available completed NCT04204928
Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC Not Available Not Available approved_for_marketing NCT03645928
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors treatment 2 recruiting NCT05044728
Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest. treatment 2 unknown_status NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma treatment 1 recruiting NCT06227728
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. No drug interventions Not Available Not Available recruiting NCT05204628
A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib treatment 3 not_yet_recruiting NCT05598528
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) No drug interventions Not Available Not Available recruiting NCT02841228
Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer No drug interventions treatment 2 unknown_status NCT03794128
A Study of Personalized Neoantigen Cancer Vaccines No drug interventions Not Available Not Available completed NCT03157128
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) treatment 1 / 2 recruiting NCT02998528
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT05241028
Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer treatment 2 recruiting NCT00312728
A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT) treatment 2 completed NCT00549328
Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT04984811
NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC treatment 2 active_not_recruiting NCT03337711
Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI Technology of Burning Rock No drug interventions Not Available Not Available unknown_status NCT01147211
Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 unknown_status NCT03865511
MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib treatment 2 active_not_recruiting NCT05395611
Exhaled Breath Particles in Lung Cancer No drug interventions Not Available Not Available recruiting NCT03647111
Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer Not Available Not Available recruiting NCT04919811
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC treatment 2 recruiting NCT03557411
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC treatment 2 unknown_status NCT05491811
Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation treatment 2 recruiting NCT06114511
A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT06426511
ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC treatment 2 not_yet_recruiting NCT01385111
Combined Application of EBUS and EUS in Lung Cancer No drug interventions diagnostic Not Available completed NCT03384511
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. treatment 4 completed NCT03050411
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer treatment 1 unknown_status NCT03240393
Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 withdrawn NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT01549093
Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT05519293
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation No drug interventions treatment 1 / 2 recruiting NCT03215693
X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib treatment 2 active_not_recruiting NCT05397093
ITIL-306 in Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02738593
Detection Cell Free DNA in Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT04487093
Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT01708993
Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy treatment 2 completed NCT01903993
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR" treatment 2 completed NCT01593293
Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer treatment 3 unknown_status NCT00880971
Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer No drug interventions treatment 3 completed NCT03334071
Exercise Intervention During Chemotherapy in Advanced Lung Cancer Patients No drug interventions treatment Not Available unknown_status NCT00503971
Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. treatment 1 / 2 terminated NCT01936571
Usefulness of Blood Biomarkers for Overall Survival in NSCLC No drug interventions Not Available Not Available completed NCT06299371
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations treatment 2 not_yet_recruiting NCT00960271
Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT00636571
Feasibility of Exercise With Post-Op Lung Cancer Patients No drug interventions supportive_care Not Available completed NCT01237171
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer No drug interventions Not Available Not Available withdrawn NCT04146571
Expanded Access to Ensartinib for Participants With ALK+ NSCLC Not Available Not Available available NCT05954871
Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer treatment 1 active_not_recruiting NCT03258671
IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT01628471
MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT06088771
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC treatment 1 / 2 recruiting NCT03485378
Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease No drug interventions treatment Not Available active_not_recruiting NCT06333678
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT02080078
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline treatment 1 terminated NCT02780778
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer screening 2 / 3 unknown_status NCT01774578
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer treatment 2 / 3 terminated NCT04028778
Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC treatment 3 unknown_status NCT01853878
A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor No drug interventions treatment 2 completed NCT04147078
Personalized DC Vaccine for Postoperative Cancer No drug interventions treatment 1 recruiting NCT01029678
Concomitant Radio-chemotherapy in the Elderly treatment 2 completed NCT01196078
A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer treatment 4 completed NCT00886678
A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801) treatment 2 unknown_status NCT03807778
A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT02574078
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT01063478
Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC treatment 1 terminated NCT03915678
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors treatment 2 recruiting NCT00661778
A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer treatment 2 completed NCT03784378
Continued Access to RXDX-105 treatment 1 completed NCT05565378
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer treatment 2 recruiting NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT04769388
Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib treatment 2 unknown_status NCT03704688
Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT06277388
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment. No drug interventions Not Available Not Available recruiting NCT03504488
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) treatment 1 / 2 recruiting NCT00372788
AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen treatment 2 completed NCT00327288
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients treatment 1 completed NCT05486988
ctDNA as a Biomarker for Treatment in Advanced NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04263688
Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion No drug interventions Not Available Not Available unknown_status NCT03258788
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT05104788
A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer treatment 2 recruiting NCT04181788
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT00063388
Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer treatment 2 completed NCT03838588
The Tracking Molecular Evolution for NSCLC (T-MENC) Study No drug interventions Not Available Not Available unknown_status NCT01159288
Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes No drug interventions treatment 2 completed NCT00173888
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00577707
Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) treatment 2 completed NCT00252707
Iressa 2nd Line Phase III Study in Japan treatment 3 completed NCT03823807
A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC No drug interventions treatment 2 unknown_status NCT00668707
Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality No drug interventions prevention 3 completed NCT04274907
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression treatment 1 terminated NCT00273507
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 treatment 3 terminated NCT01669707
Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT01188707
A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT00062907
Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer treatment 1 unknown_status NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies No drug interventions supportive_care Not Available completed NCT04541407
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease treatment 1 completed NCT04843007
Alvopem® (Pemetrexed) Safety Assessment Not Available Not Available completed NCT03782207
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice Not Available Not Available active_not_recruiting NCT03946007
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors No drug interventions Not Available Not Available completed NCT02643407
Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer treatment 3 unknown_status NCT05815407
Expressiona and Diagnostic Potential of miRNAs in NSCLC No drug interventions Not Available Not Available completed NCT05974007
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC Not Available Not Available recruiting NCT00777309
A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04702009
Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer No drug interventions treatment 2 / 3 not_yet_recruiting NCT04616209
Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients No drug interventions treatment 1 / 2 recruiting NCT00753909
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer treatment 2 completed NCT02661009
Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method) No drug interventions Not Available Not Available unknown_status NCT05077709
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC treatment 2 active_not_recruiting NCT01726309
Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4 No drug interventions Not Available Not Available terminated NCT02737709
Paclitaxel Detection in NSCLC Treated With TC Regimen treatment 2 terminated NCT01442909
Pemetrexed Followed by Docetaxel or in Reverse Sequence treatment 4 completed NCT06483009
Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC No drug interventions treatment 4 not_yet_recruiting NCT02029209
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer basic_science 2 / 3 unknown_status NCT01424709
Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT03107156
Understanding Evidence-Based Practice Patterns in Advanced NSCLC No drug interventions supportive_care Not Available completed NCT04262856
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT01561456
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung treatment 2 completed NCT05441956
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 active_not_recruiting NCT00617656
Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma treatment 3 terminated NCT05451056
An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to Sotorasib treatment 2 not_yet_recruiting NCT01146756
MEK Inhibitor and Thoracic Radiotherapy Trial treatment 1 completed NCT02462356
Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT03413956
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01809756
The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy No drug interventions prevention Not Available terminated NCT03401385
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) treatment 1 recruiting NCT00293085
An Open, Randomized, Multicentre, Phase II Pilot Study treatment 2 completed NCT03753685
X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases treatment 2 unknown_status NCT00850785
Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 completed NCT00684385
An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck Not Available Not Available approved_for_marketing NCT04913285
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors treatment 1 recruiting NCT03998085
Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC treatment Not Available unknown_status NCT05212285
Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT06561685
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06331585
Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy No drug interventions basic_science 2 withdrawn NCT02134015
Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) treatment 3 terminated NCT05104515
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine No drug interventions treatment 1 recruiting NCT04969315
TT-10 as a Single Agent in Subjects With Advanced Selected Solid Tumors treatment 1 / 2 active_not_recruiting NCT01562015
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT00372515
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations treatment 1 completed NCT00887315
The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05800015
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer treatment 2 / 3 recruiting NCT04273815
A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets treatment 1 / 2 unknown_status NCT05725915
Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT02570815
Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer treatment 1 recruiting NCT02062515
Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency treatment 2 unknown_status NCT04992715
PD-L1 Expression in Lung Cancer No drug interventions diagnostic 2 recruiting NCT04791215
Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab No drug interventions Not Available Not Available recruiting NCT06405815
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04025515
Molecular Profiling Project No drug interventions Not Available Not Available recruiting NCT00960115
Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy treatment 1 / 2 completed NCT00497315
Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03803137
Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection No drug interventions other Not Available unknown_status NCT04324437
eRAPID: Online Symptom Reporting in Lung Cancer No drug interventions other Not Available completed NCT02274337
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT03576937
Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study No drug interventions Not Available Not Available completed NCT06147037
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT03808337
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease No drug interventions treatment 2 recruiting NCT03417037
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer treatment 3 withdrawn NCT00176137
Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 3 completed NCT03878537
Recurrence Monitoring in NSCLC Using Circulating Tumor DNA No drug interventions Not Available Not Available unknown_status NCT02755337
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase No drug interventions Not Available Not Available unknown_status NCT02014337
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors treatment 1 completed NCT01542437
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer treatment 2 completed NCT01714037
A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC] treatment 1 terminated NCT05061537
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors treatment 1 terminated NCT01312337
Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT05502237
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT02162537
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases other 3 terminated NCT02950337
Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer No drug interventions treatment Not Available active_not_recruiting NCT00923637
Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer treatment 2 unknown_status NCT01038037
First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT03829332
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007) treatment 3 completed NCT01451632
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers treatment 1 completed NCT00682032
The Effect of Beta-glucan in Non-Small Cell Lung Cancer No drug interventions basic_science Not Available recruiting NCT04571632
Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors treatment 2 unknown_status NCT04145232
AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies. Not Available Not Available unknown_status NCT00964132
Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT06295432
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21) treatment 2 recruiting NCT05183932
Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05195632
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT04566432
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients No drug interventions Not Available Not Available recruiting NCT00870532
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer treatment 1 completed NCT00745732
Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT00455052
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors treatment 1 completed NCT02824952
Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC treatment 2 unknown_status NCT01596452
Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology No drug interventions Not Available Not Available unknown_status NCT00211952
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients treatment 3 suspended NCT00269152
Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer treatment 2 completed NCT04878952
Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer No drug interventions supportive_care Not Available terminated NCT05816252
A Study of SKB264 for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT06054152
CX3CR1+T Cell Predict Immunotherapy Efficacy No drug interventions Not Available Not Available active_not_recruiting NCT01038752
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer treatment 2 terminated NCT00322452
First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia treatment 3 completed NCT00932152
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT01441752
Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients No drug interventions treatment 3 completed NCT02485652
Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung treatment 2 terminated NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population No drug interventions Not Available Not Available active_not_recruiting NCT04656652
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) treatment 3 active_not_recruiting NCT03178552
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) treatment 2 / 3 recruiting NCT06349252
Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer No drug interventions Not Available Not Available recruiting NCT02256852
Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer No drug interventions treatment 2 completed NCT04212052
Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT05306652
Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment No drug interventions supportive_care Not Available recruiting NCT05653752
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer No drug interventions treatment 1 active_not_recruiting NCT05395052
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors treatment 1 terminated NCT04789252
Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT02054052
Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer treatment 2 completed NCT02002052
Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial treatment 2 terminated NCT01392352
HYPAZ: Hypertension Induced by Pazopanib basic_science 2 terminated NCT04743752
Obstructive Sleep Apnea Influences Efficacy of PD-1-Based Immunotherapy Against Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04945200
Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03445000
ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT01700400
Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer treatment 1 completed NCT04140500
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT00516100
Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC treatment 1 / 2 unknown_status NCT02407600
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy treatment 2 unknown_status NCT06467500
A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy treatment 2 recruiting NCT05766800
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT01362400
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT01505400
Integrated Molecular Profiling in Advanced Cancers Trial No drug interventions Not Available Not Available active_not_recruiting NCT04629300
Supportive Care Mobile Application for Patients With NSCLC No drug interventions supportive_care Not Available active_not_recruiting NCT05138900
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer No drug interventions treatment Not Available active_not_recruiting NCT06552000
Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer No drug interventions treatment Not Available not_yet_recruiting NCT03125200
Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression treatment 1 terminated NCT03724500
Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03319459
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors treatment 1 completed NCT00686959
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer treatment 3 completed NCT05608759
Exercise Prehabilitation for Patients With NSCLC Before Surgery No drug interventions supportive_care Not Available recruiting NCT05602259
PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC). No drug interventions diagnostic Not Available recruiting NCT05292859
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs No drug interventions Not Available Not Available active_not_recruiting NCT03424759
Uncommon EGFR AZD9291 treatment 2 unknown_status NCT04765059
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT02191059
Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer treatment 2 unknown_status NCT06542159
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases No drug interventions treatment 2 recruiting NCT05218759
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC diagnostic Not Available not_yet_recruiting NCT04710459
Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLC No drug interventions treatment Not Available completed NCT01255059
GWAS Research of Lung Cancer in Tianjin No drug interventions Not Available Not Available unknown_status NCT01481259
Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer No drug interventions treatment 2 / 3 unknown_status NCT04160559
Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer No drug interventions treatment Not Available withdrawn NCT05157659
[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer. No drug interventions diagnostic Not Available recruiting NCT01268059
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT01011075
Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT01641575
A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin treatment 1 terminated NCT00452075
Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy treatment 2 terminated NCT05042375
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT04777175
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT01069575
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT03006575
Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT00818675
A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1) treatment 2 terminated NCT01121575
A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer treatment 1 completed NCT00173875
Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer treatment 2 completed NCT02547675
Rociletinib (CO-1686) USA Expanded Access Program Not Available Not Available no_longer_available NCT04667975
The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy No drug interventions treatment 1 unknown_status NCT02507375
A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT01997775
Metformin in Stage IV Lung Adenocarcinoma treatment 2 terminated NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT00940875
A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT00870870
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before treatment 2 completed NCT03827070
Dry Pleurodesis With Talcum and Afatinib is Used to Treat Patients With Non-Small Cell Lung Carcinoma treatment 1 active_not_recruiting NCT05648370
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery No drug interventions Not Available Not Available recruiting NCT01635270
Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma No drug interventions treatment 2 completed NCT02085070
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases treatment 2 completed NCT02066870
Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI treatment 1 unknown_status NCT04857970
Routine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon) No drug interventions Not Available Not Available recruiting NCT02679170
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS) Not Available Not Available completed NCT02419170
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) treatment 0 withdrawn NCT01171170
Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer treatment 2 completed NCT00268970
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT00278070
Metronomic Oral Vinorelbine in Patients With Metastatic Tumors treatment 2 completed NCT06141070
Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease No drug interventions treatment 3 not_yet_recruiting NCT04604470
Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2 No drug interventions Not Available Not Available unknown_status NCT02040870
LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib treatment 1 / 2 completed NCT02346370
A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC treatment 1 terminated NCT04986670
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04484142
Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) treatment 2 active_not_recruiting NCT05989542
A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2) treatment 3 active_not_recruiting NCT00671242
Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake No drug interventions Not Available Not Available completed NCT01803542
Stereotactic Radiotherapy (SBRT) of Lung Metastasis No drug interventions treatment 2 recruiting NCT05620342
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer No drug interventions treatment 0 recruiting NCT06503042
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04787042
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 treatment 1 / 2 active_not_recruiting NCT00172042
A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) prevention 3 completed NCT01504542
Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer treatment 2 withdrawn NCT02454842
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients treatment 2 terminated NCT06486142
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study treatment 3 recruiting NCT04625699
Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment treatment 2 withdrawn NCT01153399
A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer). No drug interventions Not Available Not Available completed NCT06053099
A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19) No drug interventions diagnostic Not Available recruiting NCT03195699
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers treatment 1 active_not_recruiting NCT06254599
A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC treatment 3 not_yet_recruiting NCT05908799
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records Not Available Not Available completed NCT03382899
Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT00478699
Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) treatment 3 completed NCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors treatment 1 recruiting NCT04524299
Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC No drug interventions treatment 2 unknown_status NCT00684099
Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT02584699
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC No drug interventions treatment 2 unknown_status NCT00777699
Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors treatment 1 completed NCT00095199
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer treatment 3 completed NCT05877599
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation No drug interventions treatment 1 recruiting NCT01525199
Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. No drug interventions Not Available Not Available completed NCT00179699
Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT06424899
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC treatment 2 recruiting NCT03199599
Prognostic PET/CT Model in Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT06084806
Test-retest Evaluation of [18F]F-AraG PET No drug interventions diagnostic 2 not_yet_recruiting NCT00115206
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy treatment 4 completed NCT00198406
A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER. No drug interventions Not Available Not Available completed NCT02907606
Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study No drug interventions Not Available Not Available unknown_status NCT03705806
Palliative Thoracic ImmunoRT No drug interventions Not Available Not Available recruiting NCT05186506
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer treatment 2 not_yet_recruiting NCT02382406
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC treatment 1 / 2 terminated NCT04436406
PD-L1 Expression in Cancer (PECan Study). No drug interventions diagnostic Not Available recruiting NCT03340506
Dabrafenib and/or Trametinib Rollover Study treatment 4 recruiting NCT04875806
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 terminated NCT00388206
A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES) No drug interventions Not Available Not Available completed NCT03631706
M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) treatment 3 completed NCT05739006
Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies treatment 1 active_not_recruiting NCT04355806
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors No drug interventions Not Available Not Available unknown_status NCT02304406
Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa No drug interventions Not Available Not Available completed NCT05737706
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation No drug interventions treatment 1 / 2 recruiting NCT04797806
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC treatment 3 unknown_status NCT06205706
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT00923949
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer treatment 2 terminated NCT03117049
Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52) treatment 3 completed NCT05631249
Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C treatment 2 recruiting NCT02821949
Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy No drug interventions Not Available Not Available unknown_status NCT00578149
Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer treatment 2 completed NCT03607149
Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies treatment 4 completed NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT00199849
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine treatment 1 completed NCT03656549
Dose Individualization of Pemetrexed - IMPROVE-I treatment 2 completed NCT04348149
Lindera Obtusiloba for Non-small Cell Lung Cancer No drug interventions supportive_care Not Available unknown_status NCT06068049
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain No drug interventions Not Available Not Available recruiting NCT05120349
A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection treatment 3 recruiting NCT03574649
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer treatment 2 withdrawn NCT00826449
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT03149549
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors treatment 1 / 2 terminated NCT05358249
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation treatment 1 / 2 active_not_recruiting NCT00840749
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT03859349
The Canada Lymph Node Score: A Feasibility Randomized Controlled Trial No drug interventions diagnostic Not Available completed NCT00705549
Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer treatment 2 terminated NCT00887549
A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT00437749
A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer No drug interventions treatment 3 terminated NCT02695849
A Study of Prevalence of EGFR Mutations in Participants With NSCLC No drug interventions Not Available Not Available completed NCT05457049
Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD No drug interventions Not Available Not Available recruiting NCT02109549
Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients. No drug interventions Not Available Not Available completed NCT01610336
A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment treatment 2 completed NCT04099836
Atezolizumab and Bevacizumab in EGFR Mutant NSCLC in Patients With Progressive Disease After Receiving Osimertinib treatment 2 terminated NCT05233436
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors treatment 1 terminated NCT03556436
Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448 treatment 1 completed NCT00908336
Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen treatment 2 unknown_status NCT02195336
dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact. diagnostic Not Available unknown_status NCT04102436
Non-Viral TCR Gene Therapy treatment 2 withdrawn NCT02821936
Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer No drug interventions other Not Available unknown_status NCT04916236
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers treatment 1 unknown_status NCT03726736
Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC treatment 1 / 2 unknown_status NCT02437136
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer treatment 1 / 2 completed NCT01126736
Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer treatment 1 / 2 completed NCT03539536
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT05009836
Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC treatment 3 recruiting NCT03245736
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. treatment 2 completed NCT04069936
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC treatment 2 terminated NCT03829436
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers treatment 1 completed NCT04940936
Shared Decision Making on Radiation Dose for Lung Malignancies No drug interventions other Not Available recruiting NCT03048136
A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer treatment 3 withdrawn NCT01985113
Correlation Research of Thioredoxin Reductase in Lung Cancer No drug interventions Not Available Not Available completed NCT04108013
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC treatment 2 unknown_status NCT02947113
Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC treatment 2 withdrawn NCT00085813
Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT04552613
Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients treatment Not Available completed NCT05863013
Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer No drug interventions treatment Not Available enrolling_by_invitation NCT00431613
Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05662813
Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy treatment 2 recruiting NCT06065813
Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer treatment 2 recruiting NCT06060613
Safety and Efficacy of OBX-115 in Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05534113
Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC treatment 2 not_yet_recruiting NCT05970913
PET-CT Predicting Segement Specific Lymph Nodes Metastasis No drug interventions Not Available Not Available recruiting NCT01688713
Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer treatment 2 unknown_status NCT01296113
Chemotherapy for Lung Cancer in HIV-positive Patients No drug interventions treatment 2 completed NCT03077113
Pilot Study of Regional Lung Ventilation No drug interventions diagnostic Not Available completed NCT04589013
Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT01065818
Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET diagnostic Not Available terminated NCT00609518
A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT04137718
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation No drug interventions Not Available Not Available recruiting NCT05116618
Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged No drug interventions Not Available Not Available withdrawn NCT02486718
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] treatment 3 active_not_recruiting NCT00380718
Chemotherapy for Patients With Non-Small Cell Lung Cancer treatment 4 completed NCT03894618
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT05159518
A Study of PRT2527 in Participants With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03438318
Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer treatment 1 completed NCT03552718
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. No drug interventions treatment 1 active_not_recruiting NCT03976518
Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) treatment 2 completed NCT04071418
I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After Radiotherapy No drug interventions Not Available Not Available recruiting NCT03434418
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations treatment 2 completed NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors No drug interventions treatment 1 recruiting NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT00643318
CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT02054819
Treating NSCLC Minimal Stage IV With Curative Intent No drug interventions treatment 2 terminated NCT05363319
An Observational Study to Assess the Effectiveness and Safety of Cemiplimab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe (CEMI-LUNG) Not Available Not Available recruiting NCT01217619
Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation. treatment 2 completed NCT06139419
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC treatment 2 recruiting NCT05254119
DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS No drug interventions Not Available Not Available active_not_recruiting NCT00865319
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic 2 completed NCT02013219
A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT05195619
Personalized DC Vaccines in Non Small Cell Lung Cancer treatment 1 recruiting NCT05689619
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET) No drug interventions prevention Not Available recruiting NCT02388919
Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303） treatment 2 / 3 completed NCT03367819
Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies treatment 1 / 2 terminated NCT05997719
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC No drug interventions Not Available Not Available recruiting NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT00874419
Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation treatment 3 completed NCT04946019
MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT02803619
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis No drug interventions Not Available Not Available unknown_status NCT00457119
Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients treatment 1 completed NCT02669719
Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC treatment 2 unknown_status NCT05870319
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients treatment 3 recruiting NCT01065441
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer No drug interventions treatment 1 / 2 completed NCT01836341
Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation treatment 1 withdrawn NCT02988141
EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC No drug interventions Not Available Not Available unknown_status NCT01619241
Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT04687241
Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations treatment 3 active_not_recruiting NCT02577341
Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer treatment 2 completed NCT02299141
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT00923741
Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer No drug interventions treatment 1 completed NCT02370017
Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment No drug interventions treatment 2 unknown_status NCT06455917
TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients No drug interventions treatment 2 not_yet_recruiting NCT04691817
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy treatment 1 / 2 recruiting NCT01102517
A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT00687817
Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT03122717
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer treatment 1 / 2 active_not_recruiting NCT04866017
A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Patients With Stage III Unresectable Non-Small Cell Lung Cancer treatment 3 terminated NCT04967417
Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases treatment 2 recruiting NCT01457417
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors treatment 1 completed NCT02424617
A Study of BGB324(Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04500717
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation treatment 3 unknown_status NCT02347917
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma treatment 1 / 2 completed NCT03598517
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT03334617
Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy treatment 2 active_not_recruiting NCT04853017
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06043817
First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations No drug interventions treatment 1 / 2 recruiting NCT06284317
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. treatment 3 not_yet_recruiting NCT06142617
A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation. treatment 2 not_yet_recruiting NCT01350817
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer treatment 2 completed NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers treatment 1 completed NCT05565417
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas treatment 1 / 2 recruiting NCT00531934
A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer. treatment 2 completed NCT04872634
A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment treatment 1 / 2 unknown_status NCT01196234
Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer treatment 2 completed NCT05219734
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment No drug interventions Not Available Not Available active_not_recruiting NCT03833934
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance No drug interventions Not Available Not Available completed NCT02197234
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC treatment 1 active_not_recruiting NCT03791034
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC No drug interventions Not Available Not Available recruiting NCT01647334
Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT03655834
Dose Individualization of Pemetrexed - IMPROVE-III diagnostic 4 completed NCT01854034
Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR treatment 2 completed NCT03623334
Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy No drug interventions treatment Not Available completed NCT04265534
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC treatment 2 terminated NCT00165334
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer treatment 2 completed NCT01051934
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma treatment 1 completed NCT05765734
A Study of TAS3351 in NSCLC Patients With EGFRmt No drug interventions treatment 1 / 2 recruiting NCT05812534
Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases treatment 2 not_yet_recruiting NCT02657434
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) treatment 3 completed NCT03909334
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT00264134
Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT04595734
Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. No drug interventions Not Available Not Available recruiting NCT00582634
Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer treatment 2 completed NCT06521034
First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT04667234
Expanded Access of Sotorasib Not Available Not Available no_longer_available NCT04654234
Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy No drug interventions Not Available Not Available completed NCT05620134
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT02443324
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer treatment 1 completed NCT05380024
A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer treatment 2 unknown_status NCT02468024
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer No drug interventions treatment 3 recruiting NCT00251524
A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC treatment 2 completed NCT02991924
Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02445924
Micro RNA Genetic Signature in NSCLC Egyptian Patients No drug interventions Not Available Not Available completed NCT01347424
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography treatment 2 unknown_status NCT03664024
Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782) treatment 2 completed NCT01500824
A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer treatment 2 withdrawn NCT06196424
A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung). No drug interventions Not Available Not Available recruiting NCT00619424
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors treatment 1 completed NCT02117024
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer treatment 2 terminated NCT00997724
Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT03809624
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer treatment 1 active_not_recruiting NCT04863924
Accelerating Lung Cancer Diagnosis Through Liquid Biopsy No drug interventions Not Available Not Available active_not_recruiting NCT05965024
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT03682224
Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients treatment 3 completed NCT06208124
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02648724
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies No drug interventions treatment 1 / 2 completed NCT02898116
Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer treatment 1 / 2 completed NCT02109016
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations treatment 2 terminated NCT01605916
Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer treatment 1 completed NCT01165216
Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer treatment 1 completed NCT00155116
SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis No drug interventions Not Available Not Available unknown_status NCT01846416
A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR] treatment 2 completed NCT02157116
Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT01351116
A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy No drug interventions treatment 3 completed NCT04881916
Immune and Genomic Markers in ALK+ NSCLC No drug interventions Not Available Not Available recruiting NCT04980716
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients No drug interventions treatment 3 recruiting NCT05440916
Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer No drug interventions treatment 2 recruiting NCT02317016
Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer treatment 1 completed NCT03563716
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT02972216
Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy Not Available Not Available completed NCT05758116
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients treatment 2 recruiting NCT05940116
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT01134016
Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects treatment 1 completed NCT00476216
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT03729596
MGC018 With or Without MGA012 in Advanced Solid Tumors treatment 1 / 2 terminated NCT00489996
Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer treatment 2 completed NCT05532696
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients No drug interventions treatment 1 / 2 recruiting NCT02252796
Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer treatment 1 terminated NCT02490696
Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer No drug interventions other 2 completed NCT03317496
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies treatment 1 / 2 terminated NCT04371796
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC treatment 2 unknown_status NCT06540196
The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT02944396
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00991796
CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00881296
Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer treatment 2 completed NCT04045496
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05775796
Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013) treatment 2 recruiting NCT00981058
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin treatment 3 completed NCT02570958
ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors treatment 1 withdrawn NCT06031558
Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC No drug interventions treatment 3 recruiting NCT02768558
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC treatment 3 terminated NCT01165658
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies No drug interventions treatment 1 terminated NCT00138658
A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT01494558
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer No drug interventions treatment 2 / 3 completed NCT01163058
Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00615758
Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV treatment 2 completed NCT02784158
An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer Not Available Not Available no_longer_available NCT01183858
A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) treatment 3 completed NCT06109558
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC treatment 1 / 2 recruiting NCT04632758
Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients treatment 3 active_not_recruiting NCT02005458
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy treatment 2 completed NCT03413358
Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid treatment Not Available unknown_status NCT00988858
A Study of Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT06285058
Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT05377658
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer treatment 2 recruiting NCT02448758
Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²) No drug interventions Not Available Not Available unknown_status NCT00654758
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03412058
Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists No drug interventions other Not Available active_not_recruiting NCT02727335
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements No drug interventions Not Available Not Available completed NCT02515435
The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer treatment 2 unknown_status NCT00434135
Alimta and Gemcitabine in Non-Small Cell Lung Cancer treatment 2 completed NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT06403735
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02775435
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407) treatment 3 completed NCT05014035
Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer No drug interventions other Not Available completed NCT04951635
A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer treatment 3 recruiting NCT03236935
Phase Ib of L-NMMA and Pembrolizumab treatment 1 active_not_recruiting NCT04640935
Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC. No drug interventions Not Available Not Available completed NCT06161935
A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT02988635
Early Palliative Care on Quality of Life of Advanced Cancer Patients No drug interventions supportive_care 3 completed NCT04900935
Patient-centered, Optimal Integration of Survivorship and Palliative Care No drug interventions supportive_care Not Available recruiting NCT05573035
A Study to Investigate LYL845 in Adults With Solid Tumors No drug interventions treatment 1 recruiting NCT04379635
Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT05194735
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT02664935
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT01799135
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) No drug interventions diagnostic Not Available terminated NCT03282435
Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody No drug interventions treatment 1 unknown_status NCT01662635
Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) No drug interventions Not Available Not Available completed NCT00771563
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) treatment 3 completed NCT05898763
TEIPP Immunotherapy in Patients With NSCLC treatment 1 / 2 recruiting NCT04966663
Using ctDNA to Determine Therapies for Lung Cancer treatment 2 recruiting NCT06513663
Exercise as Maintenance Therapy in Advanced Lung Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT04619563
A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients treatment 2 unknown_status NCT04880863
Naptumomab Estafenatox (NAP) in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC treatment 2 completed NCT04900363
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC treatment 1 / 2 recruiting NCT04459663
JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy. treatment 2 unknown_status NCT01138163
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer No drug interventions treatment 2 completed NCT03647163
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors treatment 1 / 2 recruiting NCT03520686
QUILT 2.023: A Study of N-803 in Combination With Current Standard of Care vs Standard of Care as First-Line Treatment for Patients With Stage 3 or 4 NSCLC. treatment 3 active_not_recruiting NCT04690686
Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC). No drug interventions treatment 2 unknown_status NCT04035486
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2) treatment 3 active_not_recruiting NCT02630186
A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC treatment 1 / 2 terminated NCT05430386
Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC treatment 1 recruiting NCT02764086
INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer No drug interventions treatment 1 / 2 terminated NCT03228186
Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT00522886
Phase I Cetuximab and Concurrent Radio-chemotherapy treatment 1 completed NCT04121286
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China No drug interventions treatment 1 recruiting NCT03583086
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors treatment 1 / 2 active_not_recruiting NCT00339586
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene treatment 2 unknown_status NCT06498986
A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT01837186
Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT01720186
Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer No drug interventions diagnostic Not Available terminated NCT05707286
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy No drug interventions Not Available Not Available recruiting NCT00921739
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies No drug interventions treatment 1 completed NCT00137839
Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung treatment 2 completed NCT01257139
Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments No drug interventions other 3 completed NCT00351039
Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT04379739
Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT05571839
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors No drug interventions treatment 1 recruiting NCT04475939
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT02705339
Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) treatment 2 withdrawn NCT00730639
A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies treatment 1 completed NCT02271139
Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy Not Available Not Available no_longer_available NCT05172739
Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC No drug interventions basic_science 4 recruiting NCT00154739
Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05284539
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer treatment 2 recruiting NCT04629339
Study of INCB086550 in Select Solid Tumors treatment 2 terminated NCT02397239
Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05873439
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC No drug interventions treatment 0 active_not_recruiting NCT00191139
Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04791839
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT03974022
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) treatment 1 / 2 active_not_recruiting NCT05180422
A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis treatment 1 / 2 withdrawn NCT00441922
Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) treatment 3 completed NCT00556322
A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT05813522
Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC treatment 2 enrolling_by_invitation NCT03616522
A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01003522
Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer No drug interventions health_services_research 3 unknown_status NCT03711422
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC treatment 1 terminated NCT03132922
MAGE-A4ᶜ¹º³²T for Multi-Tumor No drug interventions treatment 1 active_not_recruiting NCT01630122
Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates No drug interventions Not Available Not Available completed NCT00094822
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT05537922
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy No drug interventions Not Available Not Available recruiting NCT05329025
A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT03473925
Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) treatment 2 completed NCT01655225
A Study of LY3023414 in Participants With Advanced Cancer treatment 1 completed NCT00316225
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen treatment 2 completed NCT03463525
Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases other 1 completed NCT01772225
NSCLC Burden of Illness Study No drug interventions Not Available Not Available completed NCT00508625
A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab treatment 2 completed NCT01521325
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers basic_science 1 completed NCT02387125
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 treatment 1 terminated NCT05937425
The Effect of Nurse Navigation Program on Lung Cancer Patients No drug interventions supportive_care Not Available not_yet_recruiting NCT00922025
Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients No drug interventions Not Available Not Available completed NCT05161325
A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan No drug interventions Not Available Not Available completed NCT01031225
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04835025
Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer No drug interventions Not Available Not Available suspended NCT00480025
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer treatment 3 terminated NCT04575025
Special Drug Use-results Surveillance of Tabrecta Tablets Not Available Not Available active_not_recruiting NCT04762030
Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study treatment 2 recruiting NCT04512430
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients treatment 2 terminated NCT04238130
Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection No drug interventions Not Available Not Available recruiting NCT06405230
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Patient-derived Organoids and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 not_yet_recruiting NCT05786430
Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib treatment 2 not_yet_recruiting NCT01014130
Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 3 unknown_status NCT04620330
A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer treatment 2 completed NCT00583830
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer treatment 2 completed NCT03754530
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation treatment 2 unknown_status NCT05010330
Identify Prognostic Biomarkers of Lung Cancer No drug interventions Not Available Not Available unknown_status NCT06020430
Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy No drug interventions treatment Not Available recruiting NCT00654030
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer No drug interventions treatment 2 completed NCT05669430
A Study of GV20-0251 in Patients With Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT03450330
Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer treatment 1 / 2 completed NCT03645330
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL) No drug interventions Not Available Not Available completed NCT05158530
Effect of Exercise Training in Lung Cancer No drug interventions treatment Not Available completed NCT04634630
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung No drug interventions Not Available Not Available completed NCT04669730
Baduanjin Exercise on Meridian Energy, Lung Function and Heart Rate Variability in Patients Undergoing Lung Operative. No drug interventions prevention Not Available unknown_status NCT04951648
A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation treatment 3 not_yet_recruiting NCT02619448
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC treatment 0 recruiting NCT03832348
Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment No drug interventions other Not Available unknown_status NCT00391248
Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) treatment 2 completed NCT04299048
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. treatment 1 completed NCT04304248
Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT05834348
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway. Not Available Not Available completed NCT05548348
First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation treatment 2 recruiting NCT03262948
Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer treatment 3 unknown_status NCT04487457
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy No drug interventions Not Available Not Available completed NCT02277457
Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations treatment 0 withdrawn NCT04564157
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy treatment 3 active_not_recruiting NCT02525757
MPDL3280A With Chemoradiation for Lung Cancer treatment 2 active_not_recruiting NCT02620657
Evaluate EGFR Mutation Status and Impact Factors in North China No drug interventions Not Available Not Available completed NCT03010657
Modifying Your Diet to Support Muscle During Cancer Treatment. No drug interventions supportive_care Not Available completed NCT01449357
Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors treatment 2 withdrawn NCT06022757
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) treatment 1 / 2 recruiting NCT01631357
Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer treatment 2 / 3 completed NCT00603057
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer No drug interventions Not Available Not Available completed NCT05020457
SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC. treatment 2 recruiting NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT05205226
Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment No drug interventions Not Available Not Available completed NCT04982926
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer No drug interventions treatment 1 active_not_recruiting NCT00260026
Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer treatment 2 completed NCT04485026
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma No drug interventions treatment 2 withdrawn NCT02155426
Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy No drug interventions Not Available Not Available unknown_status NCT04442126
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT06141226
Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT00408226
Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00085826
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients treatment 3 completed NCT02640326
McMaster Catheterization for Thoracoscopic Surgery Study No drug interventions supportive_care Not Available withdrawn NCT06247826
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion No drug interventions other Not Available recruiting NCT05788926
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) No drug interventions treatment 1 recruiting NCT05458726
Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC diagnostic 2 unknown_status NCT00434226
A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L) treatment 2 terminated NCT04153526
LUCID - LUng Cancer CIrculating Tumour Dna Study No drug interventions Not Available Not Available unknown_status NCT05546866
Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm treatment 2 recruiting NCT00509366
Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer treatment 2 terminated NCT04609566
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors treatment 2 recruiting NCT01108666
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT06481566
Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial No drug interventions treatment Not Available recruiting NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) treatment 1 / 2 recruiting NCT01130766
Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 3 unknown_status NCT06020066
SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI No drug interventions treatment 2 recruiting NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients other 2 recruiting NCT01788566
A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer treatment 2 completed NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients No drug interventions diagnostic 2 recruiting NCT03496766
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS treatment 2 terminated NCT04592666
Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer treatment 2 unknown_status NCT00912366
Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy No drug interventions Not Available Not Available terminated NCT05705466
Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 withdrawn NCT01146366
Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT02718066
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01487265
Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib treatment 2 completed NCT05252065
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT06232265
An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore No drug interventions Not Available Not Available recruiting NCT06580665
Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer No drug interventions treatment Not Available not_yet_recruiting NCT05519865
A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC treatment 2 active_not_recruiting NCT06463665
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's of Choice Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer (VIRO-25) treatment 2 not_yet_recruiting NCT01342965
A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations treatment 3 completed NCT02710565
Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma No drug interventions basic_science Not Available completed NCT00686465
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study No drug interventions treatment Not Available completed NCT04449874
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation treatment 1 recruiting NCT00391274
Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT03728374
Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma treatment 2 unknown_status NCT05921474
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors No drug interventions Not Available Not Available recruiting NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers treatment 1 / 2 completed NCT05631574
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer No drug interventions treatment 1 recruiting NCT05275374
XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation treatment 1 / 2 not_yet_recruiting NCT04405674
Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC treatment 2 recruiting NCT01017874
A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer treatment 3 completed NCT01513174
Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone treatment 1 / 2 completed NCT02433574
Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection No drug interventions treatment Not Available unknown_status NCT04998474
FRAME-001 Personalized Vaccine in NSCLC No drug interventions treatment 2 unknown_status NCT05812274
Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients No drug interventions supportive_care Not Available not_yet_recruiting NCT04470674
Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients treatment 2 withdrawn NCT01767974
Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00434174
Safety of Everolimus and Pemetrexed in Lung Cancer Patients treatment 1 completed NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT06253520
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer treatment 1 recruiting NCT03457220
An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00428220
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. treatment Not Available completed NCT00101920
ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT03311620
Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate No drug interventions diagnostic Not Available completed NCT02410382
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer treatment 2 terminated NCT04997382
Immunochemotherapy or Chemotherapy in ALK-rearranged 5'-ALK NSCLC treatment 2 completed NCT00200382
Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer treatment 2 terminated NCT00065182
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer treatment 2 completed NCT01387282
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2) treatment 3 completed NCT04638582
Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT00217282
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT05789082
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation treatment 1 / 2 recruiting NCT00702182
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer treatment 1 completed NCT02754882
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer treatment 3 completed NCT06140082
Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression No drug interventions Not Available Not Available not_yet_recruiting NCT06238882
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. treatment Not Available recruiting NCT05492682
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer treatment 1 recruiting NCT06103682
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) No drug interventions treatment Not Available recruiting NCT05094882
Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010) No drug interventions Not Available Not Available recruiting NCT04144582
Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT03525782
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC treatment 1 / 2 unknown_status NCT05736731
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT03576131
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 terminated NCT06388031
ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI treatment 2 not_yet_recruiting NCT04631731
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity No drug interventions diagnostic 1 / 2 recruiting NCT04926831
Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC treatment 2 completed NCT04054531
Study of KN046 With Chemotherapy in First Line Advanced NSCLC treatment 2 unknown_status NCT01112631
Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy No drug interventions Not Available Not Available completed NCT05037331
Osimertinib for Advanced EGFR-positive NSCLC Patients No drug interventions Not Available Not Available recruiting NCT04124731
Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) treatment 2 unknown_status NCT00383331
Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer treatment 2 terminated NCT03425331
Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC treatment 2 terminated NCT00480831
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) treatment 2 completed NCT00965731
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer treatment 1 completed NCT03906331
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation Not Available Not Available available NCT05657873
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT05859373
To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. treatment 1 / 2 not_yet_recruiting NCT02358473
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer treatment 1 completed NCT01480973
Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer No drug interventions treatment Not Available completed NCT01999673
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer treatment 3 completed NCT04944173
SCION: SABR and Checkpoint Inhibition of NSCLC No drug interventions treatment 2 withdrawn NCT03429673
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients No drug interventions Not Available Not Available completed NCT05005273
A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00789373
A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer treatment 3 completed NCT04087473
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC No drug interventions Not Available Not Available recruiting NCT00698373
Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study No drug interventions Not Available Not Available completed NCT05451173
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC treatment 1 / 2 not_yet_recruiting NCT04736173
Study Comparing the Combination Domvanalimab and Zimberelimab With Pembrolizumab in Untreated Locally Advanced or Metastatic PD-L1-High Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT04825873
A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China No drug interventions Not Available Not Available completed NCT06195527
PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04629027
Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC No drug interventions Not Available Not Available unknown_status NCT04444427
Evaluation of GLR2007 for Advanced Solid Tumors No drug interventions treatment 1 / 2 completed NCT03654027
Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC treatment 2 unknown_status NCT00097227
Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00534027
A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT06348927
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC treatment 2 not_yet_recruiting NCT06029127
A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer treatment 2 recruiting NCT03403127
PET CT Re-Planning NSCLC (4DCT-PET) No drug interventions diagnostic Not Available completed NCT03674827
Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC No drug interventions treatment 1 terminated NCT03916627
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients treatment 2 recruiting NCT06205927
Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT01258127
Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available unknown_status NCT00246727
Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer No drug interventions treatment 3 unknown_status NCT05560776
Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC No drug interventions diagnostic Not Available not_yet_recruiting NCT05628376
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO No drug interventions Not Available Not Available recruiting NCT01377376
A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib treatment 3 terminated NCT02994576
Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer treatment 2 completed NCT01091376
Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) treatment 2 unknown_status NCT04655976
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy treatment 2 / 3 active_not_recruiting NCT04470076
Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation treatment 2 unknown_status NCT06472076
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) treatment 3 recruiting NCT06041776
Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations No drug interventions treatment 3 recruiting NCT01660776
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology No drug interventions Not Available Not Available completed NCT01379976
Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer treatment 3 terminated NCT01049776
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line treatment 2 terminated NCT05522660
Immunotherapy or Targeted Therapy with or Without Stereotactic Radiosurgery for Patients with Brain Metastases from Melanoma or Non-small Cell Lung Cancer No drug interventions treatment 3 recruiting NCT05790460
Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer No drug interventions health_services_research Not Available terminated NCT03571360
CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients No drug interventions treatment 2 unknown_status NCT02515760
Tumor-specific T Cells in Lung Cancer No drug interventions basic_science Not Available active_not_recruiting NCT03472560
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) treatment 2 terminated NCT05902260
The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC No drug interventions treatment Not Available recruiting NCT06496360
Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT03087760
Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer treatment 2 completed NCT01301560
Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis No drug interventions treatment 3 unknown_status NCT00544960
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer treatment 2 completed NCT01423760
Common Safety Follow-up Trial of Tecemotide (L-BLP25) treatment Not Available terminated NCT00531960
A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer. treatment 2 completed NCT05286294
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders treatment 2 recruiting NCT00273494
Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 No drug interventions treatment 3 unknown_status NCT00695994
The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients treatment 2 completed NCT01206894
Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound No drug interventions diagnostic Not Available completed NCT00832494
Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04495894
Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma other 0 recruiting NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02220894
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042) treatment 3 completed NCT05375994
Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients treatment 1 / 2 recruiting NCT02222194
The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer No drug interventions Not Available Not Available completed NCT02463994
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC treatment 0 completed NCT03372694
Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients No drug interventions treatment 3 unknown_status NCT00325494
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer treatment 1 completed NCT01067794
Chemotherapy in Treating Patients With Lung Cancer Not Available Not Available completed NCT01218594
Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer treatment 2 unknown_status NCT02064491
Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC treatment 2 completed NCT03797391
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04266691
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT05116891
A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors treatment 1 / 2 completed NCT06507891
A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets treatment 1 / 2 terminated NCT05252091
An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC No drug interventions treatment 2 unknown_status NCT02554591
Genomic Landscape of Ceritinib No drug interventions Not Available Not Available terminated NCT05033691
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases No drug interventions treatment Not Available recruiting NCT00343291
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC treatment 2 completed NCT00425191
Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. treatment 2 completed NCT03616691
Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC treatment 2 unknown_status NCT02965391
Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients No drug interventions Not Available Not Available completed NCT00191191
To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03511391
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors treatment 2 completed NCT05569291
Investigating the Feasibility of a Physical Activity (Tele)Coaching Intervention in Patients With Non-small Cell Lung Cancer: an Explorative Study No drug interventions treatment Not Available recruiting NCT01844791
An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients treatment 2 completed NCT04358562
Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib treatment 2 unknown_status NCT02071862
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors treatment 1 completed NCT00706862
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer treatment 3 unknown_status NCT05116462
Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer treatment 3 recruiting NCT04489862
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors No drug interventions treatment 0 unknown_status NCT02093962
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer treatment 2 terminated NCT01667562
A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 completed NCT01024062
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03746262
Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00974662
Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT00453362
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib treatment 1 / 2 completed NCT04713462
Real-world Data of Nivolumab in Pre-treated NSCLC No drug interventions Not Available Not Available completed NCT01532362
Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer prevention Not Available terminated NCT05948462
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib treatment 2 withdrawn NCT04037462
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy No drug interventions treatment 1 / 2 terminated NCT03808662
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung No drug interventions treatment 2 active_not_recruiting NCT04063462
Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation treatment 2 unknown_status NCT06385262
TOP 2301: Neoadjuvant Chemo for NSCLC treatment 2 not_yet_recruiting NCT01051362
Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT00700180
A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. treatment 2 completed NCT04042480
A Study of SGN-CD228A in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03374280
Pemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLC treatment 2 unknown_status NCT01000480
A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer treatment 2 completed NCT01005680
A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer treatment 3 completed NCT05681780
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC treatment 1 / 2 recruiting NCT03306680
SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial No drug interventions treatment 1 active_not_recruiting NCT06231680
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) treatment 2 recruiting NCT02860780
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer treatment 1 completed NCT00341380
Prevention of Tumor Spread Due to Lung Cancer Surgery No drug interventions Not Available Not Available completed NCT03808480
Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10% treatment 2 unknown_status NCT01040780
Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients treatment 3 completed NCT03735680
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer diagnostic 2 completed NCT05062980
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer treatment 1 / 2 active_not_recruiting NCT04628780
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT00832780
Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung No drug interventions treatment Not Available completed NCT01393080
Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients treatment Not Available unknown_status NCT00364780
Study of XL647 in Subjects With Non-Small-Cell Lung Cancer treatment 2 completed NCT05736029
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics No drug interventions Not Available Not Available recruiting NCT02713529
Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer treatment 1 / 2 completed NCT05265429
Biology of Young Lung Cancer Study: The YOUNG LUNG Study No drug interventions Not Available Not Available recruiting NCT03360929
Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 treatment 1 / 2 completed NCT00533429
Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy treatment 2 completed NCT02851329
Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors No drug interventions Not Available Not Available unknown_status NCT06010329
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC No drug interventions treatment 2 recruiting NCT06382129
A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer treatment 3 recruiting NCT02839629
Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia No drug interventions Not Available Not Available completed NCT03769129
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC treatment Not Available recruiting NCT00633529
Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC Not Available 1 completed NCT06345729
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004) treatment 3 recruiting NCT03710629
A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver Genes No drug interventions Not Available Not Available unknown_status NCT04943029
Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC treatment 2 unknown_status NCT02619929
Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria Not Available Not Available completed NCT05837429
Low Volume High Intensity Interval Training in Operated Lung Cancer Patients No drug interventions treatment Not Available recruiting NCT00300729
Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy treatment 3 unknown_status NCT06020989
Lazertinib and Chemotherapy Combination in EGFR-mutant NSCLC Patients Without ctDNA Clearance After lead-in Lazertinib Monotherapy treatment 2 not_yet_recruiting NCT01899989
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT02504489
Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC treatment 3 completed NCT01920789
Stereotactic Precision And Conventional Radiotherapy Evaluation No drug interventions treatment Not Available unknown_status NCT01402089
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients treatment 4 completed NCT01858389
A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT01083589
Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02587689
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT01771289
Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC treatment 2 unknown_status NCT00663689
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer treatment 2 unknown_status NCT01259089
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03081689
Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients treatment 2 completed NCT00349089
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy treatment 2 completed NCT00255489
A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer treatment 1 completed NCT06534489
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment No drug interventions Not Available Not Available recruiting NCT00779389
Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family treatment 1 completed NCT01831089
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors treatment 1 completed NCT01103089
Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) No drug interventions Not Available Not Available completed NCT02728492
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy treatment 1 completed NCT05578092
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway treatment 1 / 2 recruiting NCT04742192
Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT06577792
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY) No drug interventions treatment Not Available recruiting NCT01336192
Maintenance Gemcitabine in the Chinese Advanced Lung Cancer treatment 4 unknown_status NCT06207292
Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03429192
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04210492
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT04956692
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86) treatment 3 active_not_recruiting NCT03232892
Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer treatment 2 terminated NCT05267392
Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy treatment 1 / 2 unknown_status NCT00666692
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03130192
A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy No drug interventions Not Available Not Available unknown_status NCT02950792
MRI Adaptive Replanning Using ViewRay No drug interventions treatment Not Available withdrawn NCT04335292
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer With Osimertinib Third-line Rechallenge treatment 2 recruiting NCT04422392
Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer treatment 2 terminated NCT03689192
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors No drug interventions treatment 1 completed NCT00350792
Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients treatment 2 completed NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers treatment 1 not_yet_recruiting NCT00401492
MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer treatment 2 completed NCT04194944
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT05049044
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE) No drug interventions Not Available Not Available active_not_recruiting NCT03850444
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)-China Extension Study treatment 3 completed NCT06436144
Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC treatment 2 not_yet_recruiting NCT00118144
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer treatment 2 completed NCT05933044
RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada Not Available Not Available completed NCT04560244
A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment treatment 2 unknown_status NCT01107444
Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT03320044
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing No drug interventions Not Available Not Available completed NCT05016544
Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT06117644
The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04544644
A Study of Combination Therapy in NSCLC treatment 2 unknown_status NCT02335944
Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer. treatment 1 / 2 terminated NCT00799240
MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer treatment 2 completed NCT05061940
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. No drug interventions Not Available Not Available terminated NCT00692640
Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors treatment 1 completed NCT01000740
A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa No drug interventions treatment 4 completed NCT02844140
DE-CT in Lung Cancer Proton Therapy No drug interventions other Not Available withdrawn NCT05312840
Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer treatment 4 recruiting NCT04396340
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b No drug interventions treatment 1 terminated NCT04398940
A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT00573040
Radiotherapy for NSCLC to a Individualized MLD No drug interventions Not Available Not Available completed NCT03987867
Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC treatment 1 unknown_status NCT01305967
Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT02460367
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer treatment 1 terminated NCT01810367
ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC treatment 2 completed NCT00769067
A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen treatment 2 completed NCT06438367
TGRX-326 Pharmacokinetic Mass Balance No drug interventions treatment 1 not_yet_recruiting NCT02459067
ImmuniCell® in Patients With Advanced Cancers No drug interventions treatment 2 terminated NCT04315467
Intraoperative Imaging of Pulmonary Nodules by SGM-101 No drug interventions other 1 completed NCT05257967
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease No drug interventions diagnostic Not Available recruiting NCT06557967
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment No drug interventions Not Available Not Available active_not_recruiting NCT00787267
Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC treatment 2 terminated NCT03193567
Study of High Efficient Killing Cell Therapy for Advanced NSCLC No drug interventions treatment 1 recruiting NCT04611867
Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) No drug interventions supportive_care Not Available recruiting NCT02682667
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols No drug interventions Not Available Not Available recruiting NCT04093167
Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC treatment 2 / 3 recruiting NCT04074967
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab treatment 1 / 2 active_not_recruiting NCT03977467
Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor treatment 2 completed NCT03481101
WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC No drug interventions diagnostic Not Available unknown_status NCT03732001
A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC treatment 2 unknown_status NCT02031601
Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer treatment 4 unknown_status NCT02469701
Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease treatment 2 terminated NCT01720901
Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy treatment 4 suspended NCT01724801
Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer treatment 3 completed NCT00801801
Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC treatment 2 terminated NCT04006301
First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation No drug interventions treatment 1 completed NCT04840004
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT00418704
Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) Not Available Not Available completed NCT00425204
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment treatment 2 completed NCT04058704
A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy treatment 3 unknown_status NCT05724004
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB) No drug interventions treatment Not Available recruiting NCT02767804
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients treatment 3 active_not_recruiting NCT05170204
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT03771404
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy" No drug interventions other Not Available unknown_status NCT02364804
A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer Not Available Not Available completed NCT04886804
A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) treatment 1 recruiting NCT03801304
Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer treatment 2 completed NCT04550104
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC treatment 1 recruiting NCT03313804
Priming Immunotherapy in Advanced Disease With Radiation No drug interventions treatment 2 active_not_recruiting NCT00378404
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC treatment 1 terminated NCT02151604
Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy diagnostic 2 completed NCT03053804
Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction No drug interventions diagnostic Not Available unknown_status NCT01222572
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT01833572
Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001) treatment 2 completed NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors diagnostic 2 recruiting NCT00966472
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC treatment 1 completed NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05221372
ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) No drug interventions Not Available Not Available recruiting NCT01242072
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies No drug interventions treatment 1 unknown_status NCT01167972
Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma No drug interventions Not Available Not Available completed NCT03860272
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer treatment 1 recruiting NCT06448572
EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy. No drug interventions treatment 1 / 2 not_yet_recruiting NCT01460472
Immunotherapy With Racotumomab in Advanced Lung Cancer treatment 3 unknown_status NCT04892472
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT04946968
Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers treatment 2 recruiting NCT02001168
Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB prevention 3 unknown_status NCT00434668
Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer treatment 2 completed NCT01137968
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT00816868
A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung treatment 2 completed NCT03219268
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms treatment 1 completed NCT02726568
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases treatment 2 unknown_status NCT06198868
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC No drug interventions Not Available Not Available recruiting NCT04735068
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT05275868
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT03156868
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma No drug interventions Not Available Not Available completed NCT01823068
Vandetanib in Advanced NSCLC With RET Rearrangement treatment 2 completed NCT00940069
TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer treatment 2 completed NCT04078269
MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT05636969
Assessment of Cardiorespiratory Fitness and Lung Function in Lung Cancer Patients Undergoing NAT No drug interventions Not Available Not Available recruiting NCT05789069
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT02410369
Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy treatment 1 / 2 recruiting NCT03924869
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867) treatment 3 active_not_recruiting NCT05007769
Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC treatment 2 withdrawn NCT01387269
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) treatment 3 completed NCT03632369
Hyperpolarized Noble Gas MRI Detection of Radiation-Induced Lung Injury No drug interventions Not Available Not Available withdrawn NCT02467569
Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer No drug interventions treatment 1 terminated NCT04175769
A Nutritional Supplement to Support People With Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03447769
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A treatment 3 terminated NCT03653546
First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metastases treatment 2 / 3 completed NCT05210946
A Single-Arm Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients treatment Not Available recruiting NCT03970746
Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC treatment 1 / 2 active_not_recruiting NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT00251446
A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02321046
An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer). No drug interventions Not Available Not Available completed NCT04003246
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT04631146
Efficacy and Safety of Camrelizumab in Real-World Study Not Available Not Available unknown_status NCT04716946
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy treatment 2 recruiting NCT03201146
Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC treatment 1 / 2 unknown_status NCT04250246
A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 treatment 2 not_yet_recruiting NCT04027946
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT00749346
NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT01581346
Exercise Study in Patients With Lung Cancer No drug interventions Not Available 2 completed NCT02933346
Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program No drug interventions Not Available Not Available completed NCT05023746
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients No drug interventions Not Available Not Available completed NCT03392246
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer treatment 2 active_not_recruiting NCT02938546
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study No drug interventions diagnostic 3 unknown_status NCT06538012
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer treatment 1 / 2 recruiting NCT03382912
Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT05206812
Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in Operable Non-small Cell Lung Cancer (NSCLC) (MIRACLE) treatment 2 not_yet_recruiting NCT04052412
Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer No drug interventions basic_science 1 unknown_status NCT05137912
Neoadjuvant Immunotherapy in Advanced NSCLC No drug interventions Not Available Not Available unknown_status NCT01364012
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy treatment 3 completed NCT00681512
The Effect of Berries on Lung Cancer Tumors No drug interventions basic_science Not Available terminated NCT03095612
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 terminated NCT01828112
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib treatment 3 completed NCT00923312
Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 / 2 completed NCT04676412
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study treatment 3 completed NCT00867412
Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer No drug interventions Not Available Not Available completed NCT01529112
A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments treatment 2 completed NCT05295212
Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB treatment 2 recruiting NCT04430712
Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume No drug interventions Not Available Not Available completed NCT03421912
Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR) No drug interventions supportive_care Not Available completed NCT00881712
Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02) No drug interventions treatment Not Available terminated NCT04294810
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT05445310
Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT05102110
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. No drug interventions Not Available Not Available recruiting NCT03780010
Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC treatment 1 completed NCT03633110
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine treatment 1 / 2 completed NCT02405910
Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC. treatment 2 withdrawn NCT05401110
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer treatment 1 recruiting NCT00892710
Trial of Poor Performance Status Patients (ToPPS) treatment 2 completed NCT03846310
A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer treatment 1 active_not_recruiting NCT06268210
Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT00190710
A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer treatment 3 completed NCT04127110
Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients treatment 2 active_not_recruiting NCT03505710
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer treatment 2 completed NCT01230710
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression treatment 4 completed NCT06062810
Pharmacogenomics IND EXEMPT SNP Clinical Study - Crizotinib and Single Nucleotide Polymorphisms health_services_research 2 / 3 not_yet_recruiting NCT01004510
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer treatment 2 terminated NCT02714010
EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC treatment 3 unknown_status NCT02314481
Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity treatment 2 active_not_recruiting NCT04425681
Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer treatment 2 unknown_status NCT01409681
A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available terminated NCT05448781
Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC treatment 2 unknown_status NCT03476681
Study of NEO-201 in Solid Tumors Expansion Cohorts treatment 1 / 2 recruiting NCT02664181
Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial treatment 2 completed NCT00528281
A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase treatment 1 completed NCT05200481
Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK) treatment 2 recruiting NCT00721981
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy No drug interventions Not Available Not Available terminated NCT06445881
Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment No drug interventions treatment 2 recruiting NCT00883181
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy No drug interventions Not Available Not Available completed NCT04775095
BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation No drug interventions Not Available Not Available completed NCT05792995
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes treatment 2 completed NCT05460195
Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation treatment 2 recruiting NCT00462995
Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) treatment 2 completed NCT01924195
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） treatment 2 completed NCT04828395
Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT04344795
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors treatment 1 active_not_recruiting NCT04933695
A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment treatment 2 active_not_recruiting NCT05211895
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC treatment 3 recruiting NCT05642195
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer treatment 1 / 2 suspended NCT04314895
Trial of NanoPac Intratumoral Injection in Lung Cancer treatment 2 completed NCT04245514
Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT00966914
Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin treatment 3 completed NCT05514314
A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection treatment 2 not_yet_recruiting NCT02673814
Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer treatment 2 withdrawn NCT01753414
Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC No drug interventions treatment 2 active_not_recruiting NCT01395914
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) treatment 3 completed NCT02669914
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors treatment 2 terminated NCT05102214
HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00188214
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy No drug interventions diagnostic 2 completed NCT01676714
Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer treatment 2 completed NCT05273814
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer treatment 1 unknown_status NCT00753714
Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine treatment 2 completed NCT03481114
Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT00569114
Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients No drug interventions Not Available 1 completed NCT03409614
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer treatment 3 active_not_recruiting NCT03778814
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors No drug interventions treatment 1 recruiting NCT01182155
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation No drug interventions Not Available Not Available completed NCT01951755
Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT00290355
Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery No drug interventions prevention 2 completed NCT03386955
BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT04351555
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT05567055
Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations treatment 2 withdrawn NCT02409355
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) treatment 3 terminated NCT00268255
Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer treatment 1 / 2 withdrawn NCT06475755
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC treatment 2 not_yet_recruiting NCT05061550
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer treatment 2 recruiting NCT02906150
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type treatment 2 unknown_status NCT05810350
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles treatment 2 recruiting NCT06171750
Phase I Study of ANK-101 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05047250
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer treatment 3 recruiting NCT02920450
Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002) treatment 1 / 2 terminated NCT06188650
The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study treatment Not Available recruiting NCT06319950
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases treatment 2 not_yet_recruiting NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies treatment 1 completed NCT02080650
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) No drug interventions device_feasibility Not Available completed NCT00291850
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC treatment 2 terminated NCT00352950
Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer treatment 1 withdrawn NCT02439450
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04808050
Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT03924050
Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI treatment 3 recruiting NCT01282450
Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) No drug interventions Not Available 2 completed NCT05485350
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT05611450
Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy No drug interventions health_services_research Not Available not_yet_recruiting NCT02908750
Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC treatment 1 completed NCT00308750
First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03989050
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors No drug interventions Not Available Not Available withdrawn NCT03877250
Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies No drug interventions Not Available Not Available withdrawn NCT03775850
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors treatment 1 completed NCT02954523
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations treatment 1 / 2 terminated NCT02087423
A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer treatment 2 active_not_recruiting NCT03377023
Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT01891123
Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy No drug interventions treatment Not Available unknown_status NCT00871923
Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer treatment 2 completed NCT00888823
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT00073723
Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03198923
Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT04721223
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors treatment 1 / 2 unknown_status NCT03583723
Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial) No drug interventions treatment Not Available unknown_status NCT02580708
Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT00931008
Study to Evaluate SID 530 Compared to Taxotere Not Available 3 completed NCT00073008
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT05635708
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer treatment 2 recruiting NCT04530708
Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC No drug interventions treatment Not Available recruiting NCT06322108
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008) treatment 2 recruiting NCT02981108
A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC treatment 1 / 2 active_not_recruiting NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT02133508
A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib) No drug interventions Not Available Not Available completed NCT00854308
A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib) treatment 2 completed NCT06107608
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors No drug interventions diagnostic 2 recruiting NCT05785208
Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status. treatment 4 recruiting NCT00257608
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) treatment 3 completed NCT02319408
Immune Boost In Non-Small Cell Lung Cancer No drug interventions basic_science Not Available completed NCT00191308
Molecular Profiling in Lung Cancer Patients treatment 2 completed NCT05911308
Abequolixron (RGX-104) and Durvalumab in Lung Cancer treatment 1 recruiting NCT05899608
Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients treatment 3 recruiting NCT00651508
Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT01234038
Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel treatment 1 / 2 completed NCT06461338
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study No drug interventions treatment Not Available not_yet_recruiting NCT04173338
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma treatment 1 terminated NCT04816838
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations treatment Not Available recruiting NCT03169738
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors treatment 1 / 2 withdrawn NCT06538038
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients Not Available Not Available not_yet_recruiting NCT03611738
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC treatment 1 active_not_recruiting NCT05478538
Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT04383938
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies treatment 1 / 2 completed NCT01685138
LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer treatment 2 completed NCT06469138
A Phase 1 Study to Investigate 14C-bemcentinib Following Single Oral Administration in Healthy Male Subjects treatment 1 completed NCT06236438
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 / 3 recruiting NCT01687738
Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention No drug interventions treatment Not Available completed NCT06580938
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer treatment 1 not_yet_recruiting NCT04841538
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors No drug interventions treatment 1 / 2 withdrawn NCT00526643
CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients treatment 3 terminated NCT05183243
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results No drug interventions treatment 1 recruiting NCT01833143
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D treatment 2 completed NCT03425643
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) treatment 3 active_not_recruiting NCT05124743
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors No drug interventions Not Available Not Available suspended NCT01391143
Safety Study of MGA271 in Refractory Cancer treatment 1 completed NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01493843
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer treatment 2 completed NCT03060343
Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 0 unknown_status NCT03664843
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] treatment 3 recruiting NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck treatment 2 completed NCT00845143
Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT02006043
Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) treatment 2 unknown_status NCT04450043
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance No drug interventions supportive_care Not Available unknown_status NCT01015443
Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population treatment 3 terminated NCT00160043
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. treatment 2 completed NCT00212043
Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma treatment 2 completed NCT00153803
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00404703
A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer treatment 2 terminated NCT02798003
Food Reward in Cachexia Induced by Acute or Chronic Disease No drug interventions Not Available Not Available terminated NCT05005403
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of ABBV-514 Alone or in Combination With Budigalimab treatment 1 recruiting NCT06093503
Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein treatment 3 withdrawn NCT00732303
Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer treatment 2 terminated NCT06127303
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC treatment 2 not_yet_recruiting NCT06015503
A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC) No drug interventions treatment 2 recruiting NCT01941303
Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease No drug interventions Not Available Not Available completed NCT03637803
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors treatment 1 / 2 terminated NCT03565003
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China treatment 1 / 2 unknown_status NCT04933903
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab treatment 2 recruiting NCT05212103
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9 No drug interventions Not Available Not Available enrolling_by_invitation NCT04272203
A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers No drug interventions treatment 1 terminated NCT01803503
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors treatment 2 unknown_status NCT05867303
A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04322890
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation treatment 2 recruiting NCT03273790
A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan No drug interventions Not Available Not Available completed NCT01187290
Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases No drug interventions treatment 2 unknown_status NCT02914990
Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients No drug interventions treatment 1 completed NCT05647590
SBRT/RT in Oligometastatic Stage IV NSCLC No drug interventions treatment Not Available recruiting NCT01510990
First Line Gefitinib by FDG-PET Metabolic Response treatment 2 unknown_status NCT02638090
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 active_not_recruiting NCT02929290
Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC No drug interventions treatment 1 recruiting NCT02618590
A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure No drug interventions Not Available Not Available unknown_status NCT02147990
Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer treatment 2 terminated NCT04840290
A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC treatment 3 unknown_status NCT05465590
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer No drug interventions treatment 0 withdrawn NCT02658890
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread treatment 1 / 2 completed NCT00078390
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT02027090
High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease treatment 2 unknown_status NCT06496490
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality No drug interventions treatment 2 recruiting NCT06343064
Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI treatment 1 / 2 recruiting NCT03366064
Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT02040064
Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients treatment 1 completed NCT01527864
Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer treatment 2 unknown_status NCT05014464
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma Not Available Not Available recruiting NCT05698264
A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC No drug interventions treatment Not Available not_yet_recruiting NCT04253964
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy treatment 2 recruiting NCT06060964
Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management No drug interventions supportive_care 0 not_yet_recruiting NCT03743064
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02579564
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients treatment 3 unknown_status NCT05847764
Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations treatment 2 not_yet_recruiting NCT04257864
Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT06272864
BostonGene and Exigent Genomic INsight Study No drug interventions Not Available Not Available recruiting NCT03137264
Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients No drug interventions Not Available Not Available completed NCT03844464
Safety and Efficacy of Lorbrena No drug interventions Not Available Not Available recruiting NCT03870464
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect No drug interventions Not Available Not Available active_not_recruiting NCT01124864
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. treatment 2 completed NCT05769764
A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01003964
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV treatment 2 completed NCT03130764
Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC treatment 2 withdrawn NCT03074864
Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC treatment 2 / 3 unknown_status NCT03256721
Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC treatment 2 terminated NCT06492421
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. treatment 2 recruiting NCT01882621
Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients treatment 3 unknown_status NCT00864721
Sunitinib Non Small Cell Lung Cancer Patients Over 70 treatment 2 completed NCT06105021
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT02259621
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC treatment 2 active_not_recruiting NCT01045421
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies treatment 1 / 2 completed NCT00530621
Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer treatment 2 completed NCT03285321
Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03655821
Dose Individualization of Pemetrexed - IMPROVE-II treatment 4 terminated NCT00741221
Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer treatment 2 completed NCT05709821
IMM60 and Pembrolizumab in Melanoma and NSCLC treatment 1 / 2 terminated NCT03735121
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT05867121
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT05129202
Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases No drug interventions Not Available Not Available completed NCT00818402
Non-small Cell Lung Cancer and Quality of Life No drug interventions Not Available Not Available completed NCT04923802
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION) No drug interventions Not Available Not Available terminated NCT04438902
Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment treatment 2 terminated NCT05965102
Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer No drug interventions treatment 1 not_yet_recruiting NCT00800202
A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis treatment 2 completed NCT01573702
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) treatment 2 completed NCT05354102
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 treatment 1 active_not_recruiting NCT02459002
Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project No drug interventions Not Available Not Available completed NCT00606502
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment treatment 2 completed NCT01337102
Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2) No drug interventions supportive_care Not Available completed NCT06343402
Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer treatment 1 recruiting NCT04601402
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy treatment 1 completed NCT04916002
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer treatment 2 active_not_recruiting NCT03840902
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT00674102
An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT01225302
A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00717002
Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study No drug interventions Not Available Not Available completed NCT01211002
Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) treatment 4 unknown_status NCT00466284
Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer treatment 2 unknown_status NCT03509584
Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients treatment 1 terminated NCT04777084
The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined With Lenvatinib in NSCLC. No drug interventions treatment 1 recruiting NCT04491084
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy treatment 1 / 2 terminated NCT06443684
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC No drug interventions Not Available Not Available recruiting NCT00922584
Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor treatment 2 completed NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT04925284
Study of XB002 in Subjects With Solid Tumors (JEWEL-101) treatment 1 active_not_recruiting NCT05822284
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT00367679
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer treatment 2 completed NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00907179
Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT00891579
Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations treatment 2 completed NCT01017679
Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg treatment 2 completed NCT01544179
A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone treatment 3 completed NCT00188279
Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma No drug interventions diagnostic 2 completed NCT02884479
An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study treatment 1 / 2 unknown_status NCT04967079
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients treatment 1 completed NCT01130779
The Continuation of Erlotinib treatment 2 unknown_status NCT02841579
Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M treatment 2 completed NCT02087839
Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC): Phase II treatment 2 withdrawn NCT03937024
GEN1042 Safety Trial in Subjects With Malignant Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT03559881
Modifying Your Diet to Support Muscle During Cancer Treatment No drug interventions supportive_care Not Available completed NCT03368222
Pembrolizumab and SBRT in Metastatic Non-small-cell Lung Cancer Patients treatment 1 not_yet_recruiting NCT00735891
A Trial for Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer treatment 2 terminated NCT03743350
NSCLC Exon 20 or HER2-activating Mutations treatment 2 not_yet_recruiting NCT04432857
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors treatment 1 active_not_recruiting NCT02293733
Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) No drug interventions Not Available Not Available completed NCT04832854
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06128551
Study of RMC-6291 in Combination With RMC-6236 in Participants With Advanced KRAS G12C Mutant Solid Tumors No drug interventions treatment 1 recruiting NCT00821951
Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer treatment 1 completed NCT03853551
Osimertinib Study in Indian Patients treatment 4 completed NCT02458651
Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China No drug interventions Not Available Not Available completed NCT01666353
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy No drug interventions diagnostic 0 completed NCT01620853
Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test) No drug interventions Not Available Not Available completed NCT00850577
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer treatment 2 terminated NCT03559647
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy Not Available Not Available completed NCT06357598
Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer treatment 4 recruiting NCT04619797
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer treatment 2 / 3 active_not_recruiting NCT04393883
A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC) treatment Not Available unknown_status NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT02608528
Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy No drug interventions Not Available Not Available terminated NCT04908111
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 treatment 1 / 2 suspended NCT02403193
Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT06448793
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments No drug interventions Not Available Not Available not_yet_recruiting NCT01874678
A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer treatment Not Available completed NCT00770588
Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC) treatment 4 completed NCT06074588
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) treatment 3 recruiting NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) treatment 3 recruiting NCT05253807
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration treatment 2 completed NCT01438307
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02740985
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies treatment 1 completed NCT04721015
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors treatment 1 active_not_recruiting NCT04267237
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer treatment 2 withdrawn NCT03549000
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. No drug interventions treatment 1 terminated NCT03407300
A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) Patients treatment 2 unknown_status NCT04044859
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) No drug interventions treatment 1 recruiting NCT01193959
Pemetrexed in Advanced Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT02036359
Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca treatment 2 unknown_status NCT00807170
Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases treatment 1 terminated NCT01336842
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors treatment 1 completed NCT06558799
LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT04083599
GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors treatment 1 / 2 recruiting NCT01359436
e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer No drug interventions diagnostic Not Available unknown_status NCT02066636
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen treatment 3 completed NCT02113813
A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations treatment 1 completed NCT05057013
HMBD-001 in Advanced HER3 Positive Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT04753918
Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study treatment 0 unknown_status NCT05905341
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. treatment 1 withdrawn NCT06040541
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors No drug interventions treatment 1 recruiting NCT00820417
Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib Not Available 1 completed NCT04139317
Safety and Efficacy of Capmatinib (INC280) Plus Pembrolizumab vs Pembrolizumab Alone in NSCLC With PD-L1≥ 50% treatment 2 terminated NCT05462717
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05118334
IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC) treatment 1 completed NCT01071434
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors No drug interventions Not Available Not Available terminated NCT01454934
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT03164616
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). treatment 3 active_not_recruiting NCT02820116
The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation treatment 2 unknown_status NCT03409458
A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab treatment 1 / 2 completed NCT04921358
Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 terminated NCT01188486
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer device_feasibility Not Available terminated NCT02642939
Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT04513925
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT02352948
A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer treatment 3 completed NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies treatment 1 recruiting NCT05351320
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC treatment 2 recruiting NCT03667820
Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC treatment 2 active_not_recruiting NCT04844073
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer No drug interventions treatment 1 / 2 recruiting NCT05364073
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations treatment 1 active_not_recruiting NCT05735327
A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY No drug interventions Not Available Not Available recruiting NCT02698176
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) treatment 1 terminated NCT05468294
F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer treatment 1 / 2 unknown_status NCT02840994
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer treatment 1 completed NCT02356991
A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) treatment 2 suspended NCT00971191
A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804 basic_science 1 terminated NCT03260491
HER3-DXd in Metastatic or Unresectable Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT02364362
A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT01323062
Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects treatment 1 completed NCT01028729
A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) treatment 4 unknown_status NCT02448992
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer No drug interventions treatment 2 / 3 recruiting NCT01843192
Powered Echelon Device in VATS Surgery No drug interventions Not Available Not Available completed NCT01702844
Single Arm on the Tolerability of Weekly Nab-paclitaxel treatment 2 completed NCT05661240
Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment treatment 2 / 3 not_yet_recruiting NCT05088967
Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer treatment 1 terminated NCT06232967
PPIO-006 Primary Tumor Resection for IVa NSCLC No drug interventions Not Available Not Available completed NCT05169801
To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC treatment 3 completed NCT00683904
Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer treatment 1 completed NCT01980472
Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients other 2 unknown_status NCT03217669
Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy treatment 1 active_not_recruiting NCT02456246
Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT No drug interventions diagnostic Not Available completed NCT05819346
Digital Lifestyle Intervention for Lung Cancer Survivors After Inpatient Rehabilitation No drug interventions other Not Available recruiting NCT06026410
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors treatment 1 recruiting NCT00637910
Tarceva Italian Lung Optimization tRial treatment 3 unknown_status NCT02111681
Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer No drug interventions treatment Not Available completed NCT05991895
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer Not Available Not Available recruiting NCT04524195
PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic 1 terminated NCT02025114
Selumetinib in Combination With Gefitinib in NSCLC Patients treatment 1 / 2 completed NCT00818714
Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516 No drug interventions treatment 1 withdrawn NCT01741155
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC) treatment 2 terminated NCT01885455
Improving Resection Rates Among African Americans With NSCLC No drug interventions health_services_research Not Available completed NCT06331455
Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection treatment 2 recruiting NCT05648955
Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment No drug interventions supportive_care 0 recruiting NCT06332755
Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04905550
Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC treatment 2 unknown_status NCT05207423
A Chart Review Study of Adults With Advanced NSCLC No drug interventions Not Available Not Available completed NCT01463423
Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) No drug interventions health_services_research Not Available completed NCT06495008
Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy No drug interventions Not Available Not Available recruiting NCT02714608
A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT06114108
Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients No drug interventions treatment Not Available recruiting NCT06476808
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. No drug interventions treatment 1 recruiting NCT01947608
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Not Available Not Available no_longer_available NCT02572843
Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02667743
Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC treatment 3 unknown_status NCT02603003
the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs treatment 1 completed NCT06454890
Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 / 2 not_yet_recruiting NCT04909164
The Prospective Non-randomized Case-control Study From Real-world Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT06162221
Study of RAS(ON) Inhibitor Combinations in Patients With Advanced RAS-mutated NSCLC treatment 1 / 2 recruiting NCT02887521
Pulmonary Rehabilitation Before Lung Cancer Resection No drug interventions supportive_care 3 terminated NCT06305754
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) and Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009) treatment 3 recruiting NCT02521051
Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT05765877
Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT04676477
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT02916745
Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer treatment 1 completed NCT02738398
FDG PET/CT in Lung Cancer Staging No drug interventions treatment Not Available active_not_recruiting NCT00148798
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX) treatment 3 completed NCT02132598
Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases treatment 2 terminated NCT01594398
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer treatment 1 completed NCT05791097
Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC. treatment 3 withdrawn NCT01005797
Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers treatment 1 completed NCT01637597
Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation No drug interventions Not Available Not Available unknown_status NCT01922583
AUY922 in Patient With Stage IV NSCLC treatment 2 completed NCT03255083
DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer treatment 1 terminated NCT04763083
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies No drug interventions treatment 1 recruiting NCT02588261
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations treatment 3 terminated NCT03735628
An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors treatment 1 completed NCT03708328
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT04563871
Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) treatment 2 completed NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers treatment 1 recruiting NCT01210378
Nitroglycerin in Non-small Cell Lung Cancer treatment 2 terminated NCT03447678
Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors. treatment 2 unknown_status NCT02392507
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC treatment 2 completed NCT02555007
Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM treatment 1 completed NCT06487156
A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Not Available Not Available recruiting NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) treatment 3 recruiting NCT05473156
A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT01999985
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS No drug interventions treatment 1 recruiting NCT03505515
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer No drug interventions Not Available Not Available completed NCT06567015
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs No drug interventions treatment 1 / 2 not_yet_recruiting NCT01282437
Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC No drug interventions treatment 3 completed NCT06416852
Clinical Study of 18F-Alfatide Injection PET/CT diagnostic 3 not_yet_recruiting NCT05419700
A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 Insertion No drug interventions Not Available Not Available completed NCT03082300
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations treatment 1 terminated NCT06431100
a Single-arm, Single-center, Open Clinical Study No drug interventions Not Available Not Available recruiting NCT03693300
A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer treatment 2 completed NCT00285675
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 treatment 2 unknown_status NCT02196675
Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea No drug interventions Not Available Not Available completed NCT03725475
A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients No drug interventions Not Available Not Available completed NCT01204099
Study of PX-866 and Docetaxel in Solid Tumors treatment 1 / 2 completed NCT03997799
Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT01300299
STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO) No drug interventions treatment Not Available withdrawn NCT00492206
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC treatment 2 completed NCT00683306
Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment Not Available Not Available approved_for_marketing NCT02997449
Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered No drug interventions Not Available Not Available unknown_status NCT05737849
A Study to Learn About the Tests Looking for a Gene Mutation in Adults With Lung Cancer in China (ELEGANT) No drug interventions Not Available Not Available withdrawn NCT01720836
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT05589818
Pembrolizumab for Advanced NSCLC and PS 2-3 treatment 2 recruiting NCT00227019
Phase 2 Trial of Bevacizumab in Combination With Pemetrexed treatment 2 completed NCT05863819
A Real World Study of Mobocertinib in Adults With Lung Cancer in China (MEANING) No drug interventions Not Available Not Available withdrawn NCT04424641
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 terminated NCT02404441
Phase I/II Study of PDR001 in Patients With Advanced Malignancies treatment 1 / 2 completed NCT04945317
ROSE for Improved Molecular Marker Testing Via EBUS No drug interventions other Not Available enrolling_by_invitation NCT01712217
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib treatment 1 / 2 completed NCT02988817
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT02879617
A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients treatment 2 completed NCT05100134
Managed Access Programs for LDK378, Ceritinib Not Available Not Available available NCT02662634
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer treatment 2 withdrawn NCT05553834
PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung treatment 2 recruiting NCT02014324
Single Scope Staging of Lung Cancer With Endosonography No drug interventions Not Available Not Available completed NCT05271916
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations treatment 1 / 2 recruiting NCT02380196
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT03775486
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION) treatment 2 active_not_recruiting NCT05141786
A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC). treatment 2 unknown_status NCT02221739
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT01574222
A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer No drug interventions treatment 1 terminated NCT01808430
Powered Echelon Device in VATS Surgery No drug interventions Not Available Not Available completed NCT01994057
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment No drug interventions Not Available Not Available recruiting NCT01905657
Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010) treatment 2 / 3 completed NCT01951157
A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients treatment 2 completed NCT01964157
An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement treatment 2 unknown_status NCT02771626
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 terminated NCT02639026
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers treatment 1 completed NCT02839265
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT05585320
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04338620
Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC treatment 2 active_not_recruiting NCT02316327
Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab treatment 4 completed NCT04180176
Prospective Clinicogenomic Program No drug interventions other 4 completed NCT04751162
A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device. No drug interventions Not Available Not Available completed NCT01498562
Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer treatment 2 completed NCT01137162
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors No drug interventions Not Available Not Available terminated NCT05801029
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations treatment 2 recruiting NCT04772989
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies treatment 1 active_not_recruiting NCT02927340
A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions treatment 2 unknown_status NCT03197467
Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer treatment 2 completed NCT03207867
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma treatment 2 terminated NCT06267001
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy treatment 3 recruiting NCT02016872
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients No drug interventions diagnostic Not Available completed NCT06162572
Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 recruiting NCT00323869
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer treatment 2 completed NCT05100069
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer Not Available Not Available recruiting NCT04667312
Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom Not Available Not Available completed NCT04026412
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery treatment 3 active_not_recruiting NCT04677595
Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation treatment 2 active_not_recruiting NCT05711914
Predicting Response to PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging and Clinical Data No drug interventions Not Available Not Available completed NCT04189614
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer No drug interventions treatment 1 active_not_recruiting NCT03893955
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT00820755
Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC) treatment 3 completed NCT01134250
Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients treatment 1 / 2 completed NCT05721950
A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC) Not Available Not Available recruiting NCT06191250
--SuPERIOR Trial-- treatment 2 not_yet_recruiting NCT04576208
A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788 prevention 2 withdrawn NCT00793208
Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 terminated NCT00641238
Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA) No drug interventions Not Available Not Available completed NCT00274443
An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin treatment 2 completed NCT00517790
Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05068102
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab treatment 1 recruiting NCT04830202
Expanded Access to Telisotuzumab Vedotin Not Available Not Available available NCT03523702
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial. No drug interventions treatment 2 active_not_recruiting NCT01465802
Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO treatment 2 completed NCT02409342
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] treatment 3 completed NCT01850303
Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer treatment 3 completed NCT03562819
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer). No drug interventions Not Available Not Available completed NCT01639001
A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients treatment 3 completed NCT02522910
An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 withdrawn NCT02688166
Cardiac MRI Biomarker Testing (GCC 1618) No drug interventions Not Available Not Available terminated NCT06585644
A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC No drug interventions treatment 2 not_yet_recruiting NCT02552121
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT02279732
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin treatment 3 completed NCT02001623
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT06130254
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers treatment 1 recruiting NCT01871454
Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers treatment 2 recruiting NCT05639751
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation treatment 1 recruiting NCT05538572
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT05701787
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations No drug interventions Not Available Not Available recruiting NCT04370587
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT06332287
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis treatment 2 recruiting NCT05710133
The Food-effect on Alectinib Pharmacokinetics No drug interventions other Not Available active_not_recruiting NCT04930133
Retrospective Multi-cohort Study of Frontline Afatinib Followed by 2nd Line Therapy Including Osimertinib, Chemotherapy or Other Therapy Not Available Not Available unknown_status NCT04741633
Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy No drug interventions Not Available Not Available unknown_status NCT02140333
Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC treatment 3 unknown_status NCT05378633
The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases? No drug interventions treatment 2 recruiting NCT06255951
Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects treatment 1 recruiting NCT03990077
Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC treatment 1 terminated NCT06081777
Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05663177
Almonertinib Plus Metronomic Oral Vinorelbine Not Available Not Available not_yet_recruiting NCT04712877
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers No drug interventions Not Available Not Available recruiting NCT05273047
RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC No drug interventions Not Available Not Available active_not_recruiting NCT03955198
A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation treatment 2 active_not_recruiting NCT03601598
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC treatment 1 / 2 unknown_status NCT05383898
Study to Evaluate D-1553 in Subjects With Lung Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT05988697
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib Not Available Not Available not_yet_recruiting NCT04405661
Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC No drug interventions Not Available Not Available unknown_status NCT04677361
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab treatment 0 withdrawn NCT03893461
Coagulation System In STereotactic Radiotherapy Of NSCLC No drug interventions Not Available Not Available unknown_status NCT05902728
Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects treatment 1 completed NCT06326411
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors No drug interventions treatment 1 recruiting NCT02778893
Conmana Combined With Thalidomide to Treat NSCLC treatment 4 unknown_status NCT04986293
CPAP or BiPAP for Motion Mitigation During Radiotherapy No drug interventions other Not Available recruiting NCT04764188
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib Not Available Not Available active_not_recruiting NCT04950907
Uniportal Tubeless VATS for the Evaluation of Biopsy for Second-generation Sequencing in Patients With Advanced NSCLC No drug interventions diagnostic Not Available unknown_status NCT03453307
Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT04419207
Detecting Lung Cancer Based on Exhaled Breath No drug interventions Not Available Not Available completed NCT04670107
The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy treatment 1 / 2 completed NCT04557007
Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients Not Available Not Available recruiting NCT00924209
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer treatment 2 terminated NCT03812809
A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive No drug interventions treatment 2 completed NCT06496009
The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients No drug interventions Not Available Not Available not_yet_recruiting NCT01553656
Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer treatment 1 completed NCT06431685
Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer treatment 1 recruiting NCT05132985
Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma treatment 2 not_yet_recruiting NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors treatment 3 recruiting NCT03636685
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC treatment 1 / 2 unknown_status NCT03744715
A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib treatment 2 terminated NCT00298415
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) treatment 3 completed NCT04575415
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study Not Available Not Available unknown_status NCT02526537
Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients No drug interventions Not Available Not Available terminated NCT03546452
A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC No drug interventions Not Available Not Available unknown_status NCT05577052
SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases No drug interventions treatment Not Available not_yet_recruiting NCT04778800
A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY) treatment Not Available unknown_status NCT06479759
LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 recruiting NCT02573259
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors No drug interventions treatment 1 completed NCT03634059
A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations treatment Not Available unknown_status NCT04199559
Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT00702975
Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy treatment 2 completed NCT02404675
High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation treatment 4 unknown_status NCT06221670
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK) treatment 2 not_yet_recruiting NCT05002270
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation treatment 1 / 2 recruiting NCT04506242
Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer treatment 2 not_yet_recruiting NCT06339242
A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis No drug interventions treatment 2 recruiting NCT02691299
A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer treatment 3 completed NCT02500199
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors treatment 1 unknown_status NCT02121899
Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006) No drug interventions Not Available Not Available terminated NCT05991206
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC No drug interventions Not Available Not Available recruiting NCT05778149
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation treatment 2 not_yet_recruiting NCT06328049
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC prevention 2 recruiting NCT06480136
SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment treatment 2 not_yet_recruiting NCT05605613
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial No drug interventions treatment 2 / 3 recruiting NCT05882513
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer treatment 2 recruiting NCT00072618
Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients treatment 1 / 2 completed NCT03394118
TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy treatment 2 completed NCT05146219
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation No drug interventions treatment 2 active_not_recruiting NCT04780217
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT00283634
A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT06317324
Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With Interlobular Fissure Invasion. No drug interventions Not Available Not Available recruiting NCT05463224
Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients treatment 2 recruiting NCT02976116
A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT06029816
Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations treatment 2 not_yet_recruiting NCT04504916
A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) treatment 2 terminated NCT06094296
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03265496
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation No drug interventions diagnostic Not Available terminated NCT06317558
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy No drug interventions Not Available Not Available recruiting NCT03766958
A Registry to Evaluate the Performance of the BDX-XL2 Test No drug interventions Not Available Not Available completed NCT04007835
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI treatment Not Available unknown_status NCT06576635
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients treatment Not Available not_yet_recruiting NCT04585035
Study to Evaluate D-1553 in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04772235
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients treatment 1 recruiting NCT02973763
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer treatment 1 unknown_status NCT01697163
De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors No drug interventions Not Available Not Available unknown_status NCT06315686
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA treatment 2 recruiting NCT04720339
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy. No drug interventions other Not Available recruiting NCT04989322
Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC treatment 2 recruiting NCT02029222
Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients. No drug interventions Not Available Not Available completed NCT05160922
Crizotinib Continuation Clinical Study treatment 4 active_not_recruiting NCT02121925
Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up No drug interventions Not Available Not Available terminated NCT04276025
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma No drug interventions Not Available Not Available completed NCT04549025
Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen treatment 2 terminated NCT01998425
Circulating Fibrocytes in Non-small Cell Lung Cancer. No drug interventions Not Available Not Available unknown_status NCT05332925
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC No drug interventions Not Available Not Available recruiting NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors No drug interventions treatment 1 recruiting NCT01579630
Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy treatment 2 / 3 unknown_status NCT03030430
Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects treatment 1 completed NCT01368848
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) treatment 2 completed NCT01219348
IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. No drug interventions treatment 1 completed NCT02226757
Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients treatment 2 unknown_status NCT06108726
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer treatment 2 recruiting NCT03513666
A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment No drug interventions treatment 2 completed NCT03810066
Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS) treatment 2 completed NCT04969965
To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations No drug interventions treatment 1 completed NCT05332574
A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT04135820
A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711 No drug interventions other 1 completed NCT03875820
Phase I Trial of Defactinib and VS-6766. health_services_research 1 active_not_recruiting NCT02300831
LUMINIST: LUng Cancer Molecular Insights Non Interventional Study No drug interventions Not Available Not Available completed NCT03741231
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy No drug interventions Not Available Not Available completed NCT05994131
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC treatment 1 / 2 recruiting NCT05959473
EGFR_IUO 3.20 Clinical Study Protocol No drug interventions diagnostic Not Available withdrawn NCT04204473
A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation No drug interventions treatment 1 completed NCT02272127
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer treatment 2 unknown_status NCT04996927
18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT05273827
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium Not Available Not Available completed NCT04413227
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors treatment 1 unknown_status NCT01100827
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status No drug interventions Not Available Not Available unknown_status NCT05532527
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study treatment Not Available not_yet_recruiting NCT04720976
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05684276
DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors treatment 2 recruiting NCT00752076
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment No drug interventions basic_science Not Available unknown_status NCT05165160
Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis No drug interventions other Not Available recruiting NCT04313660
Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study treatment 2 unknown_status NCT02631460
S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC treatment 2 unknown_status NCT05058560
Tislelizumab in Addition to BACE in Patients With NSCLC treatment 2 active_not_recruiting NCT03058094
A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI treatment 3 withdrawn NCT03269162
Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection treatment 3 unknown_status NCT06050980
Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation No drug interventions treatment 1 recruiting NCT06247280
Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation No drug interventions Not Available Not Available active_not_recruiting NCT06362980
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations treatment 1 recruiting NCT00172380
Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III treatment 2 completed NCT01024829
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC No drug interventions treatment Not Available unknown_status NCT05773092
A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC treatment 2 recruiting NCT05602792
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02179567
Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC treatment 2 terminated NCT04958967
Phase Ib Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation No drug interventions treatment 1 withdrawn NCT03799601
Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC treatment 4 unknown_status NCT05277701
Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations treatment 2 not_yet_recruiting NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT02279004
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care No drug interventions Not Available Not Available recruiting NCT04858204
Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT05756972
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC treatment 2 / 3 active_not_recruiting NCT02954172
Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC treatment 3 completed NCT05005468
A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. treatment 2 unknown_status NCT05426668
Validation of the TheraSure CNI Monitor Under Immune Checkpoint Therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy No drug interventions Not Available Not Available unknown_status NCT06218069
Immuno-pet iMaging resPonses administeRed Immune checkpoiNt inhibiTor treatment 2 / 3 not_yet_recruiting NCT04556669
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT03448146
A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction treatment 3 completed NCT01562210
Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC treatment 1 completed NCT06315010
REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis treatment 2 not_yet_recruiting NCT06246110
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC treatment 2 recruiting NCT03256981
Stereotactic Body Radiotherapy for the Treatment of OPD treatment 2 / 3 active_not_recruiting NCT01864681
Combination of Metformin With Gefitinib to Treat NSCLC treatment 2 completed NCT01963195
Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy treatment 2 unknown_status NCT00683514
Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer treatment 3 completed NCT05999214
99mTc-H7ND SPECT/CT Imaging in NSCLC No drug interventions diagnostic Not Available recruiting NCT01861223
Afatinib Plus Nimotuzumb for NSCLC treatment 1 / 2 unknown_status NCT04820023
Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment No drug interventions treatment 1 / 2 terminated NCT05500508
Oral AMXT 1501 Dicaprate in Combination With IV DFMO treatment 1 / 2 suspended NCT05693090
Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer treatment 1 withdrawn NCT04870190
Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases treatment 3 unknown_status NCT01690390
Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease treatment 2 unknown_status NCT04146064
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response No drug interventions Not Available Not Available recruiting NCT00259064
Iressa v BSC (Best Supportive Care) in First Line NSCLC treatment 2 / 3 completed NCT06424821
Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC treatment 2 recruiting NCT04032821
To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects No drug interventions treatment 1 completed NCT02283021
Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC) No drug interventions Not Available Not Available unknown_status NCT05417321
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03073902
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum. No drug interventions Not Available Not Available completed NCT04390984
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients basic_science 1 unknown_status NCT04909684
Dose Tapering and Early Discontinuation to InCreAse cosT-effectIveness Of Immunotherapy for NSCLC treatment 3 recruiting NCT02369484
Afatinib in NSCLC With HER2 Mutation treatment 2 completed NCT04522687
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer No drug interventions Not Available Not Available recruiting NCT05222087
PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study No drug interventions treatment 1 recruiting NCT05821933
RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC treatment 1 / 2 recruiting NCT04135833
A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711 other 1 completed NCT01941654
ATOM_local Ablative Therapy No drug interventions treatment 2 completed NCT03246854
A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer No drug interventions treatment 1 terminated NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT02315053
PET Response During Chemoradiation of Lung Cancer No drug interventions treatment Not Available completed NCT06010277
Folinic Acid for Prevention of Pemetrexed-induced Toxicity prevention 4 recruiting NCT05034445
Whether Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients With Lung Cancer No drug interventions Not Available Not Available completed NCT05492045
A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT04164745
Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer treatment 2 unknown_status NCT03965845
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors treatment 1 / 2 completed NCT05987345
Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT05798845
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer treatment 2 recruiting NCT01261598
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival No drug interventions Not Available Not Available completed NCT05065398
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation No drug interventions treatment 2 unknown_status NCT04476797
Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC treatment 1 / 2 terminated NCT04871997
A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC) No drug interventions Not Available Not Available completed NCT05103683
First in Human Study of TORL-1-23 in Participants With Advanced Cancer No drug interventions treatment 1 recruiting NCT05550961
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch No drug interventions Not Available Not Available recruiting NCT06182761
A Study of Sunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT00655161
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation treatment 2 completed NCT03986528
Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 4 unknown_status NCT03353428
Intervention of Engineered Immune Effector T Cells Against Lung Cancer No drug interventions treatment 1 / 2 withdrawn NCT05382728
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO) treatment 3 recruiting NCT00269828
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. treatment 3 terminated NCT05021328
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC treatment 1 recruiting NCT04367311
Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) treatment 2 recruiting NCT03656393
To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma treatment 3 unknown_status NCT02856893
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE) treatment 2 active_not_recruiting NCT05991193
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT05207371
Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC No drug interventions treatment 1 / 2 recruiting NCT03562871
IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC treatment 1 / 2 completed NCT06001671
Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC No drug interventions treatment 1 completed NCT01829971
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection No drug interventions treatment 1 terminated NCT01852578
Cabazitaxel in Relapsed and Metastatic NSCLC treatment 2 completed NCT06050278
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens No drug interventions Not Available Not Available recruiting NCT03301688
The Pharmacokinetics and Safety of Single-dose and Parallel Comparisons in Patients With NSCLC Treated With JS001 treatment 1 completed NCT04691388
The Efficacy and Safety of Antinib Hydrochloride Combined With Sindilumab in Advanced NSCLC Patients No drug interventions treatment 2 unknown_status NCT05583188
Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC treatment 4 terminated NCT02501707
Echocardiography for RILI Prediction No drug interventions Not Available Not Available terminated NCT00831909
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN No drug interventions Not Available Not Available completed NCT02975609
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT01290809
Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients No drug interventions Not Available Not Available completed NCT05387109
Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer treatment 4 unknown_status NCT05209256
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC treatment 2 / 3 not_yet_recruiting NCT03861156
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer treatment 2 completed NCT02869685
Consistency Analysis of PD-L1s in Advanced NSCLC Tissues and in Plasma Exosomes Before and After Radiotherapy No drug interventions treatment Not Available completed NCT02326285
Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB treatment 2 / 3 terminated NCT05668585
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors treatment 1 / 2 recruiting NCT06414915
Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation treatment 2 not_yet_recruiting NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy No drug interventions Not Available Not Available unknown_status NCT02145637
Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT05547737
Multicenter, Prospective, Real World Study of Camrelizumab in Cross-line Treatment of Non-small Cell Lung Cancer Not Available Not Available not_yet_recruiting NCT05909137
Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT02515032
Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia No drug interventions treatment Not Available completed NCT04545632
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor No drug interventions Not Available Not Available completed NCT03464032
A Study of BCD-135 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT06020352
The Efficacy and Safety of KN046 Combined With Axitinib treatment 2 / 3 recruiting NCT06332300
An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC treatment 2 withdrawn NCT03801200
Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC treatment 2 unknown_status NCT04640259
Epidemiology of Young Lung Cancer - Survey No drug interventions Not Available Not Available recruiting NCT02183870
EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer treatment 2 completed NCT00866970
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia No drug interventions treatment 2 completed NCT03606070
Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study No drug interventions diagnostic Not Available unknown_status NCT04044170
Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation treatment 2 terminated NCT05615142
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. No drug interventions treatment 1 recruiting NCT05180799
A Phase 1/2 Study of BA3071 as Monotherapy and in Combination With a PD-1 Blocking Antibody (Currently Enrolling Patients With Nonsquamous or Recurrent NSCLC (Type IIB, IIIA, IV) treatment 1 / 2 recruiting NCT03866499
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients treatment 3 active_not_recruiting NCT04077099
REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT02890849
Clinical Research for the Consistency Analysis of PD-L1 in Cancer Tissue and Plasma Exosome No drug interventions treatment Not Available completed NCT00478049
Iressa as Second Line Therapy in Advanced NSCLC-Asia treatment 3 completed NCT06502249
Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s) No drug interventions Not Available Not Available not_yet_recruiting NCT04892849
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy No drug interventions Not Available Not Available recruiting NCT05466149
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion treatment 2 recruiting NCT04114136
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies treatment 2 recruiting NCT02385136
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases prevention 1 / 2 unknown_status NCT06032936
BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations treatment 1 terminated NCT00294736
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens treatment 1 completed NCT01719536
Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients treatment 3 completed NCT04826913
High Throughput Screening Device Based on 3D Nano-matrices and 3D Tumors With Functional Vascularization No drug interventions Not Available Not Available unknown_status NCT05948813
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases treatment 2 recruiting NCT02607813
Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations treatment 1 terminated NCT04261413
Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic NSCLC No drug interventions treatment 1 recruiting NCT03609918
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing No drug interventions Not Available Not Available completed NCT06090318
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss treatment 1 / 2 withdrawn NCT06116019
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) No drug interventions Not Available Not Available recruiting NCT04292119
Lorlatinib Combinations in Lung Cancer treatment 1 / 2 unknown_status NCT03465241
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS No drug interventions Not Available Not Available completed NCT03718117
Descriptive Observational Study ALK-2016-CPHG No drug interventions Not Available Not Available completed NCT06570317
Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC Not Available Not Available recruiting NCT05061017
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) treatment 2 completed NCT06095934
Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment No drug interventions treatment Not Available recruiting NCT02652234
Study of Endostar Subcutaneous Injection in NSCLC treatment 1 unknown_status NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors treatment 2 recruiting NCT05089916
Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study treatment 2 recruiting NCT02382796
A Rollover Protocol of Dacomitinib For Patients In Japan treatment 2 completed NCT04223596
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients treatment 2 active_not_recruiting NCT06142058
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC No drug interventions Not Available Not Available recruiting NCT04858958
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation No drug interventions treatment 1 recruiting NCT05117658
Study of HA121-28 in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT02069158
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor treatment 1 completed NCT03798535
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy No drug interventions Not Available Not Available active_not_recruiting NCT04419935
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy No drug interventions Not Available Not Available active_not_recruiting NCT05378763
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations treatment 3 suspended NCT05798663
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC prevention 2 recruiting NCT06462963
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT) No drug interventions treatment Not Available not_yet_recruiting NCT06107686
A Study of YL202 in Selected Patients With Advanced Solid Tumors No drug interventions treatment 2 active_not_recruiting NCT02387086
Gefitinib Combined With Thalidomide to Treat NSCLC treatment 2 / 3 unknown_status NCT00522639
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation No drug interventions diagnostic 3 terminated NCT03318939
Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation treatment 2 terminated NCT03428022
Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC treatment 3 unknown_status NCT05059522
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing treatment 3 active_not_recruiting NCT00576225
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL treatment 3 withdrawn NCT01172925
Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer treatment 2 unknown_status NCT04646330
A Trial of AK104 Plus Anlotinib in NSCLC treatment 1 / 2 unknown_status NCT05877430
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT02563548
A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors treatment 1 completed NCT06329648
Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT00874848
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT04863248
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) treatment 2 terminated NCT03767348
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab treatment 2 recruiting NCT02766348
Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients treatment 2 unknown_status NCT05341557
A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma No drug interventions treatment 1 not_yet_recruiting NCT05286957
MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC treatment 2 recruiting NCT03634826
Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer). No drug interventions Not Available Not Available unknown_status NCT01769066
Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC treatment 2 / 3 completed NCT05687266
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations treatment 3 recruiting NCT04252365
Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer treatment 2 unknown_status NCT02354274
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine® No drug interventions treatment Not Available recruiting NCT01105182
Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors No drug interventions Not Available Not Available unknown_status NCT05383482
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 treatment 1 / 2 recruiting NCT04686682
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors No drug interventions treatment 1 / 2 recruiting NCT01100931
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) treatment 1 / 2 completed NCT03416231
Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC) treatment 2 unknown_status NCT05078931
A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients treatment 2 unknown_status NCT06361927
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients No drug interventions treatment 2 recruiting NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors treatment 1 completed NCT06400160
Clinical Trial of TB511 in Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT06532591
Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC treatment 2 not_yet_recruiting NCT06054191
Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations treatment 2 not_yet_recruiting NCT05714891
Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT06097962
Safety and Efficacy of NK510 to Treat NSCLC treatment 0 recruiting NCT06534762
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study treatment 2 recruiting NCT05009329
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China treatment 1 / 2 active_not_recruiting NCT01932229
An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib treatment 2 unknown_status NCT06457789
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer other Not Available not_yet_recruiting NCT00280189
Study of Outcomes of Radiofrequency Ablation of Lung Tumors No drug interventions Not Available Not Available suspended NCT05987644
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements treatment 1 / 2 recruiting NCT03794544
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer treatment 2 completed NCT04874844
JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety No drug interventions treatment 2 / 3 unknown_status NCT04328844
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers treatment 1 active_not_recruiting NCT01742767
Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC treatment 2 unknown_status NCT05636267
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients treatment 1 / 2 recruiting NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT04811001
Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations treatment 2 recruiting NCT04553601
Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer No drug interventions diagnostic Not Available unknown_status NCT04939701
Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants No drug interventions treatment 1 / 2 terminated NCT05493501
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer treatment 3 terminated NCT00242801
Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study treatment 3 completed NCT04333004
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy treatment 1 / 2 unknown_status NCT00082472
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) treatment 1 / 2 unknown_status NCT03164772
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC treatment 1 / 2 completed NCT02482168
Study of the CD40 Agonistic Monoclonal Antibody APX005M treatment 1 completed NCT05546268
Study of Oral MRT-2359 in Selected Cancer Patients treatment 1 / 2 recruiting NCT01851369
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas treatment 1 / 2 completed NCT04944069
Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis treatment Not Available not_yet_recruiting NCT05651269
Milciclib in Combination With Gemcitabine in Advanced NSCLC treatment 2 not_yet_recruiting NCT00620269
Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III treatment 2 unknown_status NCT05688046
Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients No drug interventions Not Available Not Available completed NCT06448910
Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC treatment 2 recruiting NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT05840510
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) treatment 1 active_not_recruiting NCT04816981
AI-EBUS-Elastography for LN Staging No drug interventions diagnostic Not Available completed NCT02175381
Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC treatment 1 / 2 completed NCT01560195
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy No drug interventions prevention 3 unknown_status NCT02759614
Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations treatment 3 unknown_status NCT04807114
A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC Not Available Not Available recruiting NCT05165355
Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma No drug interventions treatment 2 recruiting NCT05772455
A Study of XZB-0004 in Patients With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT03827850
FGFR Inhibitor in FGFR Dysregulated Cancer treatment 2 terminated NCT01859650
Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients No drug interventions Not Available Not Available completed NCT04736823
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC treatment 2 recruiting NCT06062823
Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations treatment 2 recruiting NCT06239623
ERK Inhibitor JSI-1187 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03625323
Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC treatment 2 active_not_recruiting NCT04402008
Study of Poziotinib in Japanese Patients With NSCLC treatment 1 / 2 terminated NCT02284308
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy No drug interventions Not Available Not Available recruiting NCT06465238
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC No drug interventions treatment 2 not_yet_recruiting NCT04318938
Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping treatment 2 active_not_recruiting NCT05465343
Efficacy and Safety of Furmonertinib in Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases: A Single-center, Open-label, Phase II Trial（iFORCE） No drug interventions treatment 2 unknown_status NCT02940990
SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations treatment 2 unknown_status NCT00754364
Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients treatment 2 terminated NCT02795884
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation treatment 3 withdrawn NCT00777179
Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy treatment 2 completed NCT04564079
An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network No drug interventions Not Available Not Available recruiting NCT01930825
Analysis of Treatment Outcome and Toxicity in NSCLC Patients Wither-irradiated to a High Dose for Recurrent Disease. No drug interventions Not Available Not Available completed